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PREFACE
This dissertation describes the development of vapor deposited sol-gel particles
for use in directing osteoblast behavior and their potential to be used in orthopedic tissue
engineering constructs. Several chapters in this dissertation are in preparation for
publication and/or are already published in scientific journals.
Chapter 1 is a literature review, with background information on bone biology
and osteoblast differentiation, approaches to treating damaged bone tissue, the effect of
biomaterial properties on osteoblast behavior, and the use of sol-gels as biomaterials. It
also includes the rationale, hypotheses, and specific aims for this dissertation.
Chapter 2 covers the development and characterization of a silica sol-gel vapor
deposition system that can be used to tailor the material properties of substrates. The data
in this chapter is published in the Journal of Biomedical Research Part A (2012). I
performed the majority of the research, with contributions by Hallie Holmes, Michael
VanWagner, and Natalie Hartman on the degradation, contact angle and roughness
analyses. Rupak Rajachar provided input and was a mentor on experimental design,
analysis, and paper editing. However, the conclusions presented are my own, and I am
the main author for this publication.
Chapter 3 covers the characterization of particle properties when calcium and
phosphate ions are incorporated. The data in this chapter is being prepared for
publication. I performed the majority of the research with contributions by Hallie Holmes
the contact angle analysis. Rupak Rajachar provided input and was a mentor on
experimental design, analysis, and paper editing. However, the conclusions presented are
my own, and am the main author for this publication. The data in this chapter is being
prepared for submission to the Journal of Biomedical Matierals Part A.
Chapter 4 assesses the response of osteoblasts to vapor deposited calciumphosphate sol-gel particles. The data in this chapter is being prepared for publication. I
performed the research and am the main author for this publication. Rupak Rajachar
provided input and was a mentor on experimental design, analysis, and paper editing The
data in this chapter is being prepared for submission to the Journal of Biomedical
Matierals Part A.
viii

Chapter 5 is a summary of all findings and conclusions reached in this
dissertation.
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DEFINITIONS
Alkaline Phosphatase

Enzyme localized on cell membranes found in all tissues
and in high concentration in bone, kidneys, intestines,
biliary ducts, plasma, and teeth that hydrolyzes phosphate
esters liberating inorganic phosphate. In bone, used as a
marker of osteoblast differentiation and bone remodeling

Collagen

Structural protein found in connective tissues. In bone
tissues, it is the main organic constituent and is secreted by
osteoblasts

Cyclophilin

Protein found in all cells exhibit peptidyl-prolyl cis-trans
isomerase (PPIase) activity which facilitates protein folding

Hydroxyapatite

The main inorganic constitute of bone and tooth enamel
(Ca10(PO4)6(OH)2)

in vitro

Procedure that takes place in a controlled environment
outside of a living organism (i.e., laboratory, test tube,
culture dish)

in vivo

Procedure that takes place inside a living organism

MC3T3-E1

An immortalized cell line of osteoblast precursors derived
from mice

Osteoblast

Cell that secretes bone matrix and is responsible for the
formation of bone

x

Osteocalcin

Calcium-binding noncollagenous bone matrix protein
secreted by osteoblasts that is involved in regulating
mineralization in the bones and teeth and is used as an
osteoblast differentiation marker

Osteopontin

Calcium-binding noncollagenous bone matrix protein
secreted by osteoblasts that plays a role in bone remodeling
and various immunological functions and is used as an
osteoblast differentiation marker (also known as bone
sialoprotein 1, BSP-1)

Runx2

Key transcription factor associated with differentiation of
osteoblasts (also known as core-binding factor subunit
alpha-1, Cbfa1)

Ubiquitin

Small regulatory protein present in almost all cells that
attaches to proteins tags them for proteolysis

xi

ABBREVIATIONS
α-MEM

Alpha-modified minimal essential medium

AFM

Atomic force microscopy

ALP

Alkaline phosphatase

ANOVA

Analysis of variance

Ca

Calcium

cDNA

Complementary deoxyribonucleic acid

COLI

Type I collagen

DAPI

4',6-diamidino-2-phenylindole

DMEM

Dulbecco’s modified eagle medium

DTT

Dithiothreitol

ECM

Extracellular matrix

EDS.

Energy dispersive X-ray spectrometry

FBS

Fetal bovine serum

FE-SEM

Field emission scanning electron spectroscopy

FTIR

Fourier transform infrared spectroscopy

GOI

Genes of interest

HA

Hydroxyapatite

HCl

Hydrochloric acid

HK

Housekeeping genes

NBF

Neutral buffered formalin

OCN

Osteocalcin

OPN

Osteopontin

P

Phosphate

P/S

Penicillin-streptomycin

PBS

Phosphate buffered saline

PCR

Polymerase chain reaction

PLLA

Poly-L-lactide acid

PS

Polystyrene

RNA

Ribonucleic acid
xii

Runx2

Runt-related transcription factor 2

SEM

Standard error of the mean

TCPS

Tissue-culture treated polystyrene

TEP

Triethyl phosphate

TMOS

Tetramethyl orthosilicate

Tris-HCl

Tris(hydroxymethyl)aminomethane-hydrochloric acid

TRITC

Tetramethyl rhodamine iso-thiocyanate
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ABSTRACT
Tissue engineering and regenerative medicine have emerged in an effort to
generate replacement tissues capable of restoring native tissue structure and function, but
because of the complexity of biologic system, this has proven to be much harder than
originally anticipated. Silica based bioactive glasses are popular as biomaterials because
of their ability to enhance osteogenesis and angiogenesis. Sol-gel processing methods are
popular in generating these materials because it offers: 1) mild processing conditions; 2)
easily controlled structure and composition; 3) the ability to incorporate biological
molecules; and 4) inherent biocompatibility. The goal of this work was to develop a
bioactive vaporization system for the deposition of silica sol-gel particles as a means to
modify the material properties of a substrate at the nano- and micro- level to better mimic
the instructive conditions of native bone tissue, promoting appropriate osteoblast
attachment, proliferation, and differentiation as a means for supporting bone tissue
regeneration. The size distribution, morphology and degradation behavior of the vapor
deposited sol-gel particles developed here were found to be dependent upon formulation
(H2O:TMOS, pH, Ca/P incorporation) and manufacturing (substrate surface character,
deposition time). Additionally, deposition of these particles onto substrates can be used to
modify overall substrate properties including hydrophobicity, roughness, and topography.
Deposition of Ca/P sol particles induced apatite-like mineral formation on both two- and
three-dimensional materials when exposed to body fluids. Gene expression analysis
suggests that Ca/P sol particles induce upregulation osteoblast gene expression (Runx2,
OPN, OCN) in preosteoblasts during early culture time points. Upon further
modification-specifically increasing particle stability-these Ca/P sol particles possess the
potential to serve as a simple and unique means to modify biomaterial surface properties
as a means to direct osteoblast differentiation.
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CHAPTER ONE: INTRODUCTION
BACKGROUND AND SIGNIFICANCE
Each year millions of people suffer from tissue loss or failure making it one of the
most frequent, devastating, and costly problems in human healthcare. Specifically, for
bone, 5-10% of the six million bone fractures that occur annually in the U.S. result in
nonunions or delayed unions indicating there is a growing need for the development of
material substitutes and therapies to help overcome this problem [1]. Consequently, the
fields of tissue engineering and regenerative medicine have emerged in an effort to
incorporate the fundamentals of engineering (mechanics and materials) and biological
functions (cell and gene products) to generate replacement tissues capable of restoring
native tissue structure and function [2]. Because of the complexity of biologic systems, it
has proved to be much harder to design substitute matrices for cells than originally
anticipated. Cells are affected by the chemical and molecular composition of the
implanted material, as well as by its physical (i.e. topography and mechanical) properties.
Development of materials that utilize the relationships between cells and material
chemical, physical, and mechanical properties may provide a better platform for tissue
regeneration [3]. Silica sol-gel bioactive glasses have become increasingly popular for
use in tissue engineering materials due to their simple processing methods into a variety
of shapes, the ease of control over composition and structure, and inherent
biocompatibility [4-7]. The goal of this work was to develop and characterize a
bioactive silica sol-gel surface modification system that can be used to coat materials
in order to tailor their material properties at the nano- and micro- level to better
mimic the instructive conditions of native bone tissue, promoting appropriate
osteoblast attachment, proliferation, and differentiation as a means for supporting
bone tissue regeneration.
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BONE BIOLOGY
Bone Composition
Bone is a composite material composed of roughly 22-35% organic phase, 6070% inorganic phase, and 5-8% water (Figure 1.1A). The organic phase is made up of
90% type I collagen fibers with the other 5% consisting of glycoproteins, and
glycosaminoglycans (GAGs). The inorganic phase is composed primarily of
hydroxyapatite (HA) crystals (Ca10(PO4)6(OH)2). There are two theories of how this
mineral is incorporated into the collagen fibers: (1) direct nucleation and (2) matrix
vesicle (MV) mediated matrix mineralization [8-12]. In direct nucleation, stable mineral
droplets of calcium phosphate cluster-bipolymer complexes bind to regions on collagen
fibers and diffuse through the fibrils where they solidify into an amorphous mineral,
which is then transformed into orientated apatite crystals in the direction of the collagen
fibers (Figure 1.1B) [8]. MV mediated matrix mineralization is based on calcium
phosphate crystals contained within matrix vesicles that are produced by osteoblasts.
Suggested mechanisms for this include: (i) matrix vesicles regulate ion concentrations,
leading to the formation of soluble molecular species that initiate mineral formation in
the collagen fibrils, (ii) matrix vesicles regulate ion compositions leading to the formation
of intravesicular apatite crystals that leave the vesicle and initiate mineralization; and (iii)
matrix vesicles directly associate with the collagen to initiate mineralization (Figure
1.1C)[8, 13]. The rigid HA crystals provide the compressive strength of bone, while the
collagen fibers contribute to bone’s high tensile properties. Embedded in this matrix are
osteoblasts, osteocytes, and osteoclasts [14-17]. Cortical bone has a porosity of 5-10%
and its structural unit is the osteon (also called haversian systems), composed of
concentric layers of bone (lamellae). Lacunae are small cavities within the bone matrix
that contain osteocytes. Micro-scale canals called canaliculi radiate outward from a
central canal (Haversian canal) and connect lacunae to one another, allowing for nutrient
dispersal. Haversian canals are located in the center of each osteon and contain blood
vessels and never fibers. At the periphery of each osteon is a cement line, an area of
ground substance composed mostly of GAGs. Collagen fibers and canaliculi do not cross
the cement line [18]. Osteons are arranged longitudinally, making the properties of
2

cortical bone anisotropic. In the longitudinal direction, bone strength varies from 79151MPa in tension and 131-224MPa in compression. The moduli ranges from 17-20GPa
in both tension and compression [14]. Trabecular bone is more porous that cortical bone
(50-90%) and is made up of trabeculae, which are most often characterized as rod or plate
like structures. Trabeculae consist of lamellae containing osteocytes in lacunae connected
by canaliculi. However, unlike cortical bone, the lamellae are not concentrically arranged
and do not contain central canals with blood vessels [18]. Trabecular bone also exhibits
anisiotropy. Because of the increased porosity, trabecular bone has lower ultimate
strength and modulus of elasticity, but can withstand greater strains than cortical bone
[19].

3

Figure 1.1 Structure of compact and spongy bone and apatite formation. (A) Cortical bone is organized
into osteons composted of concentric lamellae around the Haversian canal with lacunae containing
osteocytes connected by canaliculi. Cacellous bone is composed of more porous trabeculae. From SEER
Training Module [20]. Theories of collagen mineralization in bone include: (B) direct nucleation of CaP
crystals [(i) CaP clusters form complexes with biopolymer to form (ii) stable mineral droplets. (iii) The
droplets bind to regions of collagen fibers and (iv) form an amorphous phase by diffusing through the fibrils.
(iv) The amorphous phase becomes orientated apatite crystals in the direction of the collagen fibers] and (C)
MV mediated matrix mineralization [(i) matrix vesicles regulate ion concentrations, leading to the formation
of soluble molecular species that initiate mineral formation in the collagen fibrils, (ii) matrix vesicles regulate
ion compositions leading to the formation of intravesicular apatite crystals that leave the vesicle and initiate
mineralization; and (iii) matrix vesicles directly associate with the collagen to initiate mineralization]. From
Chai et al. with permission (see Appendix A) [12].

4

Osteoblast Differentiation
Osteoblasts descend from mesenchymal stem cells, which can differentiate into
many different cell types including adipocytes, myoblasts, fibroblasts, chondrocytes, and
osteoblasts. The process of differentiation of these pluripotent cells into osteoblasts is
complex and controlled by morphogens, hormones, growth factors cytokines, matrix
proteins, and the expression of lineage-specific master transcription regulators and their
co-regulatory proteins [21]. The differentiation of osteoblasts is regulated by the master
transcription factor Runx2, with the help of other transcription factors including but not
limited to osterix, ATF4, SMADs, NFATc1/calcineurin, Twist, AP-1, and TCF/LEF [22].
These transcription factors have many different signaling systems including the Wnt/βcatenin, the BMP/TGFβ, the Notch, the Hedgehog, and the FGF signaling pathways [21].
Following a lineage commitment, osteoprogentitor cells undergo a distinct
temporal sequence of gene expression that has three distinct periods: (1) proliferation and
ECM biosynthesis; (2) ECM development, maturation and organization; and (3)
extracellular matrix mineralization [21-23] (Figure 1.2).
Proliferation and Extracellular Matrix Synthesis (Days 1-12 in isolated cell
culture): During this stage, cells proliferate to form multilayers or focal nodules. This
stage is characterized by mitotic activity where cell cycle (e.g. histones which help
package newly replicated DNA) and cell growth (e.g. c-fos, c-jun, c-myc which act as
transactivation factors) genes are expressed. Genes for proteins associated with the
extracellular matrix are also expressed including type I collagen and fibronectin (cell
attachment ECM protein) [21-23]. The expression of these genes gradually decline, with
type I collagen expression maintained at a basal level in future stages of osteoblast
differentiation [23].
Extracellular Matrix Development, Maturation and Organization (Days 12-18 in
isolated cell culture): As these cells exit mitosis they further differentiate into osteoblasts
and begin expressing genes such as alkaline phosphatase (ALP), bone sialoprotein (BSP),
and type I collagen [21-23]. ALP is a noncollagenous cell-linked polypeptide that is
secreted by osteoblasts and promotes crystal formation in matrix vesicles by removing
nucleation inhibitors and is often considered one of the earliest markers of the osteoblast
5

phenotype. BSP is a noncollagenous ECM protein that is associated with cell attachment
and is also thought to help direct apatite crystal growth along collagen fibers [24]. During
this phase, signaling events occur, and a large cuboidal shaped osteoblast develops from
the spindly shaped pre-osteoblast. These cells are responsible for causing the ECM to
undergo a series of modifications in composition and organization so that it can begin
mineralization. As mineralization increases, cellular expression of ALP (often considered
one of the earliest markers of the osteoblast phenotype) will decrease [23].
Extracellular Matrix Mineralization (Days 16-20 in isolated cell culture): As
osteoblast differentiation continues, the cells begin to express genes involved in ECM
mineralization including osteocalcin, osteopontin, and collegenase. Osteocalcin, a
vitamin K dependent calcium ion binding noncollagenous matrix protein, is thought to
play a role in the body's metabolic regulation. It is also implicated in bone mineralization
and calcium ion homeostasis as well as thought to play a role in bone resorption.
Osteocalcin is only expressed post-proliferation with the onset of nodule formation.
Osteopontin, also a calcium ion binding noncollagenous matrix protein associated with
cell attachment and spreading within the matrix, is expressed during the proliferation
stage, decreases during the ECM maturation stage and is induced at the onset of
mineralization, where it reaches is maximum expression levels. Collagenase expression
begins after the proliferation stage and increases with mineralization, most likely
associated with the remodeling of the collagen ECM to support tissue organization and
mineral deposition. Cell apoptosis also occurs during this phase, possibly as a way of
regulating the number of osteoblasts that differentiate into osteocytes [21-23].
Mineralization of the matrix occurs in two steps: (1) Nucleation of calcium-phosphate
crystals and (2) crystal growth. Nucleation usually occurs in matrix vesicles, [small
membrane bound organelles containing alkaline phosphatase (cleaves phosphate
groups)], secreted by osteoblasts undergoing apoptosis and from cell processes
originating from the plasma membrane. Ion pumps are used to raise the levels of calcium
and phosphate within the vesicles. When the levels are above supersaturation, nucleation
occurs on the inner face of the membrane first. The vesicles then rupture and the crystals
continue to grow in between the collagen fibers within the ECM [24]. A portion of
6

osteoblasts that become embedded into the mineralized matrix can terminally
differentiate to become osteocytes, which support bone structure and metabolic functions.
Other osteoblasts are thought to become inactivated and elongated bone lining cells
which line the surfaces of bone [21].

Figure 1.2 Osteoblast differentiation. Osteoblast phenotype and temporal protein sequence during
differentiation from stem cell to mature osteobalast/ostocytes. Bold genes common markers chosen for
osteoblastic differentiation.

TREATMENT OF DAMAGED TISSUES
Biologic and Synthetic Grafts
Traditional methods of surgical treatment of bone injuries include biologic grafts
as well as permanent artificial prostheses. They can be classified as three types-autogenic,
allogenic, and xenogenic. Autografts (taken from host) are limited by the amount of
donor tissue available as well as the fact that a second surgical site must be created, often
creating donor site morbidity and weakening of a second tissue. Allografts (taken from
host of the same species) pose antigenicity problems and are in limited supply, especially
in emergency situations. While xenografts (taken from a different species) may be readily
available, they pose significant immunogenic problems [14, 25-27]. Synthetic prostheses
are often made out of metals such as iron, cobalt, and titanium, and/or ceramic materials.
Metal implants often have issues with fatigue, corrosion, tissue infection, while both
metal and ceramic implants have issues mechanical property mismatches between the
7

material and bone, often resulting in complete implant removal in the long term [14, 2831]. The most significant deficiency with any of the current grafting systems in both soft
and hard tissue is the lack of integration of the graft to bone tissue. Additionally, there are
often immunogenic and/or material property mismatches, leading to decreased integration
of the implant with bone tissue [27, 32]. Current existing grafting systems, both biologic
and synthetic, are not able to restore tissues to their native structural and functional
characteristics, leading to compromised graft function and long-term outcome [27, 32].
Tissue Engineering
Tissue engineering is a promising approach to creating permanent solutions for
damaged tissues that aims to develop biological substitutes capable of restoring natural
structure and function to damaged tissue [2, 14, 25, 33]. Currently, many materials are
being used, either alone or in blends for bone reconstruction including but not limited to,
natural polymers such as chitin, glycosaminoglycans (hyaluronic acid, heparin,
chondroitin-6-sulphate), alginate, fibrin, collagen, and silk, as well as synthetic polymers
like polyglycolic acid (PGA)/polylactic acid (PLA), poly-e-caprolactone, polyethylene
terephthalate, and polypropylene [25, 34-42].

Many of these scaffolds often also

incorporate additional materials including growth factors [bone morphogenic proteins
(BMPs), vascular endothelial growth factor (VEGF), platelet derived growth factor
(PDGF)], proteins [parathyroid hormone (PTH), alkaline phosphatase (ALP), fibronectin]
and calcium/phosphate based ceramics [tricalcium phosphate (TCP), hydroxyapatite
(HA),

Bioglass™

(45S5: 46.1 mol% SiO2,

26.9 mol% CaO,

24.4 mol% Na2O,

2.5 mol% P2O5)] in effort to further enhance scaffold osteogenic potential [43-51].
MATERIAL PROPERTIES INFLUENCE CELL BEHAVIOR
In order to regenerate tissues successfully, the materials used in constructs should
be chosen carefully. The chemical, physical, and mechanical properties of a material can
affect cell behavior in multiple ways including attachment, morphology, proliferation,
and gene expression. Specific cell behavior can be with property-cell interactions have
been

thoroughly

characterized.

Surface
8

chemistry,

hydrophobicity,

roughness,

topography, and mechanical properties all play a role in influencing cell behavior. Many
studies have investigated the role of these parameters on cell behavior, but few have
isolated individual properties, making it difficult to determine the extent a single property
has in influencing cell behavior and also leading to sometimes conflicting conclusions.
This interdependency of materials properties makes it important to fully characterize a
material when examining cell-material interactions.
Surface Chemistry
Surface chemistry dictates at the outset the surface character of a material and can
be one of the earliest and most influential material properties on cell behavior. However,
it is difficult to make generalizations about the effect of surface chemistry on cell
behavior due to the sheer number of material choices and surface modifications available.
The chemistry of the exposed groups on a material’s surface clearly affects cell behavior,
though the mechanisms are not always understood [52]. Surface charge and released ions
change how serum proteins and ions will interact and adsorb to the material, further
altering the surface chemistry of the material and influencing cell behavior. Osteoblasts
have been found to have increased attachment, proliferation, and differentiation on
charged surfaces and/or surfaces that release ions, possibly due to increases in the
concentration of ions and the ionic conditions needed for mineralization [53].
Surface Hydrophobicity
Surface hydrophobicity (wettability) refers to the interactions between a
material’s surface and water. Because water has a high capacity for bonding (i.e., Lewis
acid-base interactions), materials with a high surface energy have more contacts for
bonding, making them generally more hydrophilic. Contact angle measurement is the
simplest way of measuring surface hydrophobicity, with the most common technique
being the sessile drop method. The angle formed at the liquid-solid interface is the
contact angle (θ), which can range from 0 to 180°. Depending on the material’s
hydrophobicity the droplet will take a different shape-for more hydrophobic surfaces the
droplet will stay rounded (larger angle), while on more hydrophilic surfaces the droplet
will spread out (smaller angle) (Figure 1.3). Relative surface hydrophobicity of a
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material is one of the first properties to influence cells when exposed to a material.
Osteoblasts have been found to respond to surface hydrophobicity in a time dependant
manner. Osteoblasts cultured on hydrophobic surfaces have delayed attachment and
remain rounded for a longer period of time than on more hydrophilic surfaces. However,
over time the surviving cells on the hydrophobic surface will eventually attach, flatten,
and spread out across the surface, possibly due to the secretion of ECM proteins that
remodel the substrate surface [54]. Many studies have found that fibroblasts attach,
spread, and proliferate best on surfaces with hydrophilic character, with some studies
determining the strongest affinity for moderately hydrophilic surfaces, also in a time
dependent manner [55-58]. When determining the effect of surface hydrophobicity on
cell attachment, spreading, and proliferation, it is important to measure the correct time
points-measuring too early may give incorrect information about long-term cell survival
on substrates, while measuring too late will give little information about initial cell
interactions with the material [54]. More recently, evidence suggests that a cell’s
activation state and not just adhesion must be considered in evaluating cell response to
materials [59].

Figure 1.3. Contact angle measurements. Schematic of how contact angle would look on a (A)
hydrophobic surface and (B) a hydrophilic surface. Young’s equation relates the balance of forces of a liquid
drop on a solid surface.
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Surface Roughness
Surface roughness is often quantified by the arithmetic mean roughness (Ra) and
the root mean square roughness (RRMS or Rq). Ra is defined as the average distance
between surface peaks and valleys relative to the center plane of the surface and RRMS is
defined as the root mean square average of the profile height deviations from the center
plane, recorded within the evaluation length (Figure 1.4A) [60]. While these values
describe the overall roughness of the material surface they do not describe the material
topography and features. Therefore, two surfaces with similar Ra and RRMS values can
appear very different macroscopically (Figure 1.4B) [61]. In general it has been found
that osteoblasts attach better to rough surfaces while fibroblasts to smooth surfaces. Many
studies show that surface roughened implants promote osseointegration better than their
smooth counterparts, which tend to promote fibroblast adhesion [62-67]. Surface
roughness increases material surface area, potentially resulting in more opportunities for
cells to establish adhesive contact with a material [61]. Osteoblasts have better adhesion,
larger cell spreading, higher proliferation, and enhanced differentiation on substrates with
an increased surface roughness [68-72].

11

Figure 1.4. Surface roughness measurements. (A) Surface roughness is often expressed as arithmetic
roughness (Ra) or root mean square roughness (RRMS or Rq). (B) Electrospun fibers with similar RRMS values
but distinctly different topographies (scale bar =10µm). Modified from Ricotti et al. with permission (see
Appendix A) [73].

Topography
Many studies of have been done to investigate the effect of specific surface
topography on cell behavior including groves/grates, posts/islands, and pits created on
different metals and polymers. Cell attachment, morphology, proliferation and gene
expression have been found to be influenced by substrate topography as small as 100nm
in width and 75nm in depth, though cell response differs depending on cell type and
feature size and geometry [74]. In general, nano- and micro- grates have been found to
enhance cell attachment, elongate cell morphology, align cells with the nanogratings, and
lower proliferation rates [70, 74]. The effect of nanopost and nanopit on cell behavior is
more varied, with different combinations of substrate material, feature geometries, and
cell types producing differing effects on cell attachment and proliferation [74]. Both
osteoblasts and fibroblasts cultured on substrates containing randomly sized and
orientated nanoposts of varying heights had higher cell attachment, spreading,
proliferation and differentiation on surfaces containing shorter nanoposts than on
substrates containing taller structures [75, 76]. Mesenchymal stem cells cultured on
12

substrates containing nanopits differentiate into either fibroblasts or osteoblast depending
on the order or disorder of the nanopit arrays. Cells cultured on highly ordered arrays
produce cells with fibroblastic appearances, while cells on arrays that were more irregular
produced cells with an osteoblastic morphology and gene expression [77].
Mechanical Properties
Cells commonly attach to its surrounding extracellular matrix, which have an
elastic moduli ranging from 10 to 10,000Pa depending on the tissue. Therefore, cell
morphology and function can be strongly influenced by substrate stiffness [78].
Fibroblasts grown on softer substrates, show few actin stress fibers and focal adhesions
and diminished cell spreading than on stiffer surfaces [78-80]. Osteoblasts cultured on
surfaces with higher elastic moduli had enhanced differentiation and mineralization [81].
Substrate mechanical properties can also affect cell proliferation and differentiationmesenchymal stem cells can be differentiated into neurogenic, myogenic, or osteogenic
cell types by changing the stiffness of the material to mimic that of the native tissue [80].
In vivo, it is important to match the mechanical properties of a tissue engineering scaffold
as closely to that of the tissue aiming to be regenerated so that there is not a compliance
mismatch and to provide structural stability to the injury site [82].
SOL-GEL METHODS FOR GENERATING BIOACTIVE GLASSES
Bioactive glasses are silica-based materials whose matrices are porous gels
obtained by the hydrolysis and condensation-polymerization of metallic alkoxides usually
based on silicon dioxide (SiO2) network materials [83]. These materials are attractive
because of their ability, when exposed to body fluids, to generate a dynamic bio-reactive
surface microenvironment that can act as a strong bonding interface between the glass
and its hard or soft tissue environment, giving them an inherent biocompatibility [84].
The use of sol-gel processing methods is increasingly popular as a technique for
generating bioactive glass-ceramic materials because of the mild processing conditions
(ambient temperatures and biologically tolerated by-products) and simple methods for
controlling composition and structure through synthesis parameters [6, 85]. Additionally,
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these materials can be used as delivery vehicles for various inorganic and organic small
molecules including ions, drugs, enzymes, antibodies, growth factors, DNA and even
cells [7, 86-92]. Sol-gel materials can be generated in the form of fibers, powders,
xerogels, aerogels, nanoparticles, and thin films [6, 93-98]. Potential biomedical uses of
sol-gel materials include: nanoparticles used in magnetic resonance imaging (MRI),
targeted drug delivery, and magnetic separation; surface coatings for metal surgical tools,
implants, and optical and electrochemical biosensors; and scaffolds for tissue engineering
[6]. Because of the attractive processing conditions and flexibility of their composition,
bioactive glasses and ceramics are widely being explored to replace or augment both hard
and soft tissues [99]. These materials further possess the capacity to exert an inherent
active influence on cell behavior; modulated in part by surface chemistry, topography,
and active agents incorporated in the sol-based material. However, the exact balance of
these parameters that is most appropriate for directing cell function and gene expression
is not fully understood and warrants further exploration [100, 101].
Sol-gel processing methods produce ceramic materials from a colloidal
suspension of precursors (sol). The solvent is removed from the system in order to
solidify the material (gel). Precursors are usually metallic alkoxide compounds (Si-(OR)n,
where R is an organic group) such as tetraethyl- or tetramethyl-orthosilicate (TEOS and
TMOS respectively) [102]. Reactions carried out with TMOS are more volatile and
consequently more energetic, so preparation of less bulky higher S/V ratio ceramics is
much more amenable to the use of TMOS [103]. In the presence of water, the alkoxide
groups are hydrolyzed, creating silanol groups and releasing alcohol. Condensation
between silanol groups then occurs, creating Si-O-Si bonds. Extension of this reaction
leads to a silica network with pores created through the removal of water and alcohol
molecules. As the polycondensation reaction continues, colloidal mircro-particles are
formed (Figure 1.5). This colloidal solution can then be cast into shapes or used as a
coating. Over time the colloidal silica particles link together, increasing the viscosity of
the solution, to form a solid three-dimensional network (gel). The size, growth rate, and
amount of cross-linking within the particles are dependent upon several variables (e.g. sol
pH and water-alkoxide ratio) that help determine the overall physical properties of the gel
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network [83, 85]. Gels can then be cured with elevated temperatures, UV radiation, or
“aged” by storing at room temperature to increase material density. Body temperature
curing is also possible if the final material form has suitable physical properties (i.e. high
S/V in the form of particles or thin-film coatings) [102].
Additionally, inorganic-organic hybrid sol-gel materials can be formed by the
additional of a polymer early on in the sol-gel process, during the condensation phase, in
order to generate a composite material that interacts at the nano-scale and behave as a
single phase material. These hybrid materials are beneficial because they improve the
mechanical and degradation properties of the bioglass [104, 105]. Hybrid materials are
classified into two categories: (1) class I hybrids that contain molecular entanglements,
hydrogen bonding, and/or van der Waals forces; and (2) class II hybrids that also contain
covalent bonding between components and are usually synthesized by functionalizing the
polymer before introduction to the sol-gel. While these hybrids allow the generation of
materials with highly tunable material properties, there are currently several
disadvantages that must be considered when generating them [104, 106, 107]. The
polymer chosen must be soluble in the sol-gel process (i.e., H2O), and have a suitable
degradation rate. Additionally, the polymer may degrade at lower pHs (the isolectric
point of silicic acid in water is 2, where the longest gelation time occurs) so the pH may
need to be adjusted, resulting in quicker gelation times [104, 108]. Perhaps the biggest
challenge of hybrid materials is the incorporation of calcium into the material. The
calcium precursor for most sol-gel processing methods is calcium nitrate tetrahydrate
(Ca(NO3)2∙ 4H2O) because it is highly soluble, but the nitrate byproducts are cytotoxic.
This is usually addressed when the sol-gel materials are processed at high temperatures,
which removes the nitrates, but the addition of polymers into the material does not allow
for this [104, 109]. Therefore it is necessary to find a new source of calcium that will
effectively be incorporated into the silica network, when generating these hybrid
materials [104].
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Figure 1.5. Stages involved in synthesis of TMOS-based silica sol-gel. Synthesis takes places in three
distinct steps: hydrolysis, condensation, and poly-condensation. Post-synthesis processing can be used to
further consolidate network structure.

Silica Sol-Gel Bioactivity and Mineralization
It is widely accepted that silica based bioglasses have osteogenic inducing
properties. When the glass is exposed to body fluids or simulated body fluids, soluble
silica is lost in the form of Si(OH)4 into the solution, breaking Si-O-Si bonds and creating
Si-OH (silanols) at the material-solution interface. SiO2 condensates and repolymerizes at
this surface, causing the migration of Ca2+ and PO43- which forms a CaO—P2O5 rich film
on top of the SiO2 layer. This amorphous CaO—P2O5 film continues to grow through the
incorporation of calcium and phosphates from solution, and is then crystallized by
incorporation of OH- and CO32- anions to form a mixed hydroxyapatite (HA) layer
(Figure 1.6). At this point biological growth factors can adsorb into the HA layer,
contributing to the active differentiation of stem cells into osteoblasts. This dynamic
interaction creates a strong bonding interface between the glass and its hard or soft tissue
environment. In hard tissues a bond is formed as a result of the biological equivalence of
the mineral phase of bone and the growing HA layer of the bioglass material. Soft tissue
bonding occurs when collagen fibrils are chemisorbed on the SiO2 layer by electrostatic,
ionic, and/or hydrogen bonding and HA is precipitated and crystallized onto collagen
16

fiber and material surfaces [84]. The character of the HA layer that is formed at the sol
gel glass surface is dependent upon many factors including the composition of the sol
material and the physical properties (i.e. roughness, topography, surface area) of the
substrate surface. Previous work has shown that apatite formation on sol gel glasses
composed of up to 90 mol% SiO2, is enhanced due to the large surface area available and
the high concentration of silanol groups at the surface of the material. More recent work
has been focused on determining the effect of additional elements to the composition of
the bioglass including magnesium, potassium, aluminum, and iron on sol gel material’s
bioactivity, with the majority of the focus being on the addition of different amounts
calcium and phosphate to the silica network. However, the composition of a sol gel glass
that is optimum for mineral formation is not known [110, 111].
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Figure 1.6. Overview of silica sol-gel bioglass bioactivity. (i) When silica based bioglasses are exposed
to body fluids: (ii) soluble silica is lost in the form of Si(OH)4 into the solution, breaking Si-O-Si bonds and
creating Si-OH (silanols) at the material-solution interface. (iii) SiO2 condensates and repolymerizes at this
32+
surface, causing the migration of Ca and PO4 which forms a CaO—P2O5 rich film on top of the SiO2 layer.
This amorphous CaO—P2O5 film continues to grow through the incorporation of calcium and phosphates
2from solution. (iv) Hydroxyl (OH ) and carbonate (CO3 ) anions are incorporated to form a mixed
hydroxyapatite (HA) layer. At this point biological growth factors can adsorb into the HA layer, contributing to
the activation of differentiation of stem cells into osteoblasts. (v) The bioglass material and tissue create a
bond due to the biological equivalence of the mineral phase of bone and the growing HA layer.
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ION INFLUENCE ON OSTEOBLAST BEHAVIOR
In addition to the ability to enhance biomineralization, dissolution ions (e.g. Si,
Ca, P) in the surrounding dissolution medium as the bioglass network degrades have been
found to influence the behavior of many tissue-specific cell types including,
mesenchymal stem cells, osteoblasts, osteoclasts, fibroblasts, and endothelial cells; as
well as bacteria (Figure 1.7) [4]. How these ions affect cell behavior is often tested with
simultaneously using multiple ions, making it difficult to isolate the mechanisms by
which the ions work to affect cell functions.

Figure 1.7. Summary of biological effects due to ionic dissolution products of bioactive glasses.
From Hoppe et al. with permission (see Appendix A) [4].

Silica (SiO2)
Osteoblasts exposed to silicate ions have been found to have increased collagen I
production possibly through the posttranscriptional regulation of transforming growth
factor β (TGFβ) [112, 113]. Silicon is also thought to play a role in collagen crosslinking
through

the

regulation

of

prolyl-hydroxylase
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activity

and

the

binding

of

glycosaminoglycans (GAGs) to collagen, aiding collagen stabilization and preventing
degradation [113, 114]. Osteoblast precursors cultured with silica ions have also been
found to have increased adhesion, metabolic activity, and proliferation [115, 116]. Silica
ions have also been found to increase ALP activity and Runx2 and osteocalcin
expression, indicating increased osteoblast differentiation [114, 117, 118]. Additionally,
silica has been found to increase nodule formation (increased ECM mineralization) in
osteoblast cultures due to its ability to facilitate nucleation of an apatite layer when
exposed to body fluids [119].
Calcium
In bone, calcium not only is a main component of hydroxyapatite mineral, it acts
as a signaling molecule to promote various osteoblast cell functions. During bone
resorption osteoclasts direct calcium and phosphate release into the microenvironment,
Increases in the local concentration of ions, specifically calcium, creates a gradient of
chemical signals for preosteoblast migration and growth through a variety of mechanisms
including the activation of calcium sensing receptors (CaSR/CaR), increasing
intracellular calcium concentrations, and/or the extracellular signal-regulated kinase
(ERK 1/2) pathway [120-122]. Calcium also plays a role in osteoblast proliferation and
differentiation through calcium/calomodulin signaling [121]. However, the concentration
range appropriate to ensure cell viability, while promoting cell differentiation and matrix
maturation

is

still

unclear.

Several

studies

have

found

that

treatment

of

preosteoblasts/osteoblasts with calcium ions at a concentration slightly higher than
physiological increases cell proliferation, while at even higher levels cell differentiation
and matrix mineralization is increased in both monolayer and three-dimensional culture.
However, the elevated calcium levels also results in slight decreases in cell viability.
Further, excessive calcium concentrations are known to be cytotoxic [5, 122, 123].
Phosphate
Phosphate, in addition to be the other main constituent of hydroxyapatite, is an
important signaling molecule that helps

to regulate osteoblast proliferation,

transcriptional factors [Nrf2, HMGA1 and 2], signal transduction pathways [Fos-related
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antigen-1 (Fra-1), extracellular signal-regulated kinase (ERK 1/2), calcyclin, A170)],
plasma membrane and membrane transport factors [Pit-1, Annexin V], the secretion of
bone-related proteins [matrix Gla protein (MGP)], and extracellular matrix cell adhesion
protein [osteopontin] [124-128]. Additionally, cells treated with inorganic phosphate are
found to exhibit decreased extracellular matrix protein gene expression [decorin,
Tenascin C, periostin, thrombospondin, and collagens (I and III)] [125, 127]. However,
the effects of phosphate are highly dose and time dependant, with high concentrations
and exposure times increasing cell (osteoblast, chondrocyte, odontoblast) apoptosis in
addition to ultimately contributing to these cells terminal differentiation [129, 130]. The
use of phosphate releasing biomaterials is rare in the literature, possibly due to the lack of
effective phosphate dosing methods to balance cell differentiation and apoptosis [12].
NEBULIZER BASED SOL DEPOSITION OF SOL PARTICLES
The novel sol vaporization system developed for this project uses nebulizer
technology to generate vaporized sol particles at ambient conditions. A jet typecompressed air nebulizer attached to a vaporization chamber (Figure 1.8A) aerosolizes
the sol precursor solution, generating sol droplets with a large aggregate surface area that
can easily be used to modify substrate surface topography and as a delivery vehicle for
active molecules. This method allows for surfaces to be modified without the use extreme
processing conditions, (i.e. temperature and harsh solvents), minimizing uncontrolled
effects on substrate character as well as the functionality of inorganic and organic factors
delivered via the sol-vapor.
The system developed here uses a nebulizer to vapor deposit nano- and microsized particles made of silica sol gel. In a jet-type nebulizer, compressed air flows
through a narrow hole and collides with a colloidal solution from one or more inlets,
generating vapor particles through momentum transfer (physical collision) (Figure 1.8B).
The complex liquid break-up process is dependent upon the nozzle design and usually a
combination of turbulent rupture of the instable liquid column and secondary droplet
break-up [131, 132]. In its simplest form, the air flowing in to the nebulizer impinges
directly on a solid jet of liquid. Large droplets impact on the internal structure of the
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nebulizer effectively reducing the mean droplet size and distribution. Only smaller
droplets with less inertia can follow the flow of the compressed air and pass through the
spray nozzle [133, 134]. Control over the size distribution of the particles produced is
determined by the properties of the colloidal solution to a significant degree, with key
variables including species concentration (H2O: alkoxide) and pH. The method developed
here allows for a layer of sol particles to be deposited onto substrates, providing a large
surface area, and creating a unique nano-structured surface topography and controlled
modification of substrate surface properties.

Figure 1.8. Schematic of vapor deposition system. (A) A jet-type nebulizer is attached to an air
compressor and a vaporization chamber where sample is placed. (B) When air flow is applied it enters
nebulizer causing turbulence, breaking apart the sol solution and generating particles, which exit the
nebulizer and enter the vaporization chamber.

HYPOTHESES AND SPECIFIC AIMS
The ultimate goal of tissue engineering is to restore and/or regenerate tissue
structure and function, with typical approaches using engineered materials scaffolds.
However, designing materials that will lead to a practical degree of recovery are difficult
to construct, due in large part to the complexity of the dynamic chemical and physical
microenvironment of a the native extracellular matrix. Cell behavior is influenced by the
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chemical and its physical properties of a material. Therefore, development of
biomaterials that utilize the relationship between material chemical and physical
properties and cell response may provide a better platform for tissue regeneration. This
project aims to develop vapor deposited silica sol gel particles as a novel cell instructive
material system for use in composite bone and interfacial tissue engineering scaffolds.
We hypothesize that these sol particles can be used as a means to: 1) deliver soluble
bioactive factors to control cell behavior and mineral formation and 2) control
chemical and physical properties of biomaterials to be used in orthopedic tissue
engineering constructs. It is vital to understand how sol particle chemical and physical
properties influence cell behavior in order to design material constructs that are capable
of directing appropriate adhesion, proliferation, and differentiation of cells, with specific
focus on osteoblasts. Understanding these relationships will allow us to develop a
bioactive materials system to functionalize tissue engineering constructs, a focus of this
research project, the specific aims of which are:
Hypothesis 1- VAPOR DEPOSITED SOL PARTICLE CHEMICAL AND PHYSICAL PROPERTIES
CAN

BE

CONTROLLED

THROUGH

CHANGES

IN

THEIR

FORMULATION

AND

MANUFACTURING PARAMETERS.

Specific Aim 1: Design sol formulations and fabrication methods for producing vapor
deposited sol particles with controlled chemical and physical properties.
The chemical (composition, stability, hydrophobicity) and physical (size
distribution-morphology, roughness-topography) properties of vapor deposited sol
particles are dependent upon sol formulation (pH, H2O:TMOS)

and manufacturing

(deposition time, substrate composition) parameters. The goal of Aim 1 was to
manufacture and characterize a series of particles whose chemical and physical properties
are optimized to address controlling osteoblast behavior (bone formation).
Hypothesis 2- VAPOR DEPOSITED SOL PARTICLES CAN BE USED AS DELIVERY VEHICLES
FOR BIOACTIVE FACTORS AND INDUCE APATITE-LIKE MINERAL GROWTH.
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Specific Aim 2: Generate sol particles capable of controlled release of inorganic
molecules.
Sol particles were modified by incorporating calcium and phosphate ions into the
formulation process. Release kinetics and the functionality (mineral formation) of the
incorporated molecules were determined. Additionally, how the incorporation of these
molecules influences particle properties was assessed. The goal of Aim 2 was to assess
particle potential to serve as controlled delivery vehicles for incorporated inorganic
molecules and determine a specific set of parameters that facilitates biomimetic
mineralization.
Hypothesis 3- VAPOR DEPOSITED SOL

PARTICLES CAN BE USED TO DIRECT BEHAVIOR

OF OSTEOBLASTS THROUGH CELL-MATERIAL INTERACTIONS.

Specific Aim 3: Determine the relationship between vapor deposited sol particle
chemical-physical properties and osteoblast behavior.
Osteoblast

response

(adhesion,

proliferation,

differentiation,

and

ECM

development) in response to sol particles was assessed. Full characterization of the
particles used will aid in determining the relationship between the material chemicalphysical properties and cell behavior. The goal of Aim 3 was to determine the particle
formulation that best directs osteoblast behavior and ultimately aids in bone formation.
Summary of Dissertation Chapters
These aims will be discussed in a series of chapters written in the form of journal
articles for publication. Chapter 2 will characterize the development of the sol particle
vapor deposition system as a means to tailor material properties and sol formulation and
manufacturing parameters affects on the particles (AIM 1). Chapter 3 will determine the
ability to incorporate calcium and phosphate ions into the sol particles as well as the
affects of these ions on particle properties and bioactivity (AIM 2). Chapter 4 will assess
the ability of calcium-phosphate particles characterized in Chapter 3 to direct osteoblast
behavior (AIM 3). Finally, Chapter 5 will present an overall summary and conclusions of
the work from this dissertation, including an outline of the limitations of this work and
proposed future directions.
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CHAPTER TWO: DEVEOLOPMENT OF VAPOR
DEPOSITED SOL-GEL PARTICLES 1
This chapter develops methods for generating vapor deposited sol particles as well as
characterizing particle morphology, size distribution, and degradation and their affect on
substrate surface hydrophobicity and roughness. Finally initial cell behavior in response
to particles was assessed. The work in this chapter addresses Specific Aim 1.
INTRODUCTION
Surface modification and coatings for orthopedic and dental implants have been
shown to promote osseointegration and mechanical fixation, increasing long-term implant
effectiveness. In addition to surface roughening techniques, current methods of surface
coating implants include plasma spraying, sputter deposition, electrophoretic deposition,
biomimetic precipitation, and sol-gel coating [1-3]. Most established approaches have
distinct shortcomings, especially those involving high energy plasma spraying or sputter
coating [4-7]. These limitations include the introduction of surface porosity and residual
stresses at the coating interface during processing, post-implantation concerns regarding
delamination of applied coatings, and limitations in the size of treatable features [8-12].
For this reason, a significant research effort is aimed at improving the performance of
implantable materials by better understanding and applying surface modification (e.g.
chemistry, hydrophobicity, roughness, eluting coatings) to promote integration as well as
resistance to infections. Many of these efforts include the surface modification of tissue
engineering materials to make them bioactive in order to help restore and/or regenerate
cell, tissue, and organ structure and function [13-15].
Bioactive glasses are silica-based materials most prominently associated with
orthopedic applications in both traditional implants as well as hard and soft tissue
1

The material presented in this chapter was previously published in the Journal of
Biomedical Materials Research Part A. [Snyder KL, Holmes HR, VanWagner MJ,
Hartman NJ, Rajachar RM. Development of Vapor Deposited Silica Sol-Gel Particles for
Use as a Bioactive Materials System. Journal of Biomedical Materials Part A 2012 (in
press)] Reprinted with permission (see Appendix A).
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engineering materials [16]. These matrices are porous networks obtained by the
hydrolysis and condensation-polymerization of metallic alkoxides, most commonly
silicon dioxide (SiO2) [17]. Sol-gel processing methods are becoming an increasingly
popular approach for generating these glass materials because they offer simple methods
to control composition and structure, making them suitable for a variety of biomedical
applications [18, 19]. Sol-gel materials are produced when the solvent is removed from a
colloidal suspension of precursors (sol) and the material is allowed to solidify (gel). In
the presence of water, the alkoxide groups are hydrolyzed, creating silanol groups and
releasing alcohol. Condensation (polymerization) between silanol groups then occurs,
creating Si-O-Si bonds. Extension of this reaction leads to a silica network with pores
resulting from the removal of water and alcohol molecules. As the polycondensation
reaction continues, colloidal particles are formed in the solution. Over time the colloidal
silica particles link together, increasing the viscosity of the solution, to form a solid threedimensional network. Due to their mild processing conditions, sol-gel materials can as
also serve as controlled delivery vehicles for inorganic and organic small molecules (i.e.
ions, drugs, proteins, antibodies, DNA) and even cells [20-25]. These materials have an
inherently active influence on cell behavior modulated in part by ion release, surface
chemistry, and topography. Dissolution products (e.g. Si, Ca, P ions) from these bioactive
glasses can stimulate gene expression and promote osteogenesis and angiogenesis [26,
27]. The exact nature by which these materials influence gene expression and promote
tissue regeneration is not fully understood and warrants further exploration [28, 29].
The aim of this work was to develop a novel nebulizer deposition system to
generate vaporized sol-gel nanoparticles for the controlled surface modification of
biomaterial substrates at ambient temperatures and pressures. More specifically, a jet
type-compressed air nebulizer is used to aerosolize sol-based materials. In jet-type
nebulizers, compressed air passes through a narrow hole and collides with a colloidal sol
solution, generating vapor particles through momentum transfer (physical collision). The
complex liquid break-up process is usually a combination of turbulent rupture of the
instable liquid column and secondary droplet break-up [30, 31]. Large droplets impact
on internal components of the nebulizer and only smaller droplets with less inertia can
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follow the flow of the compressed air and pass through the spray nozzle [32, 33]. Control
over the vaporized particle size distribution is dictated by the formulation properties of
the colloidal sol-gel solution to a significant degree, with key variables being species
concentration (H2O: alkoxide) and pH [17, 19]. The method developed here allows for a
layer of sol particles to be deposited onto substrates, providing a large surface area, and
creating a unique nano-structured surface topography and controlled modification of
substrate surface properties. Conversely, most other sol-gel application methods
consisting of dip, spin or spray coating, generate uniform thin film sol-gels [18, 34-36].
Unlike other common bioglass processing methods, the nebulizer-based approach also
allows surfaces to be coated without the use of high temperatures or other extreme
processing conditions that may alter the substrate surface or the character of delivered
factors. This approach has the potential for easily creating complex multi-layered
biomimetic coatings-incorporating a variety of small molecules, cells, and bone-like
mineral to functionalize both traditional orthopedic-dental implants and tissue
engineering constructs. A series of vapor deposited silica particles was generated to
determine how changes of key formulation and manufacturing parameters (H2O:
alkoxide, pH, deposition time, and substrate character) affect morphology, size
distribution, and degradation behavior of particles as well as the overall surface
properties (hydrophobicity and roughness) of the substrate. Additionally, we assessed the
cellular biocompatibility by evaluating cell attachment in response to particles.
MATERIALS AND METHODS
Sol Preparation
The base sol solution used in these experiments was a 16:1 molar ratio of deionized water and tetramethyl orthosilicate (TMOS; Sigma Aldrich). The solution was
mixed in a 50ml centrifuge tube and catalyzed with 0.04M hydrochloric acid (HCl;
Sigma Aldrich) at 2μl per gram of H2O/TMOS. Catalyzed solutions were agitated for 20
minutes to ensure that the solution was completely mixed. The clear homogenous
material was allowed to rest for 30 minutes at 25°C before vaporization.
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Vaporization System and Deposition
Nebulizer-based vaporization was carried out using a jet-type nebulizer (Pari LC
Plus, Allegro Medical) attached to a 500ml vaporization chamber (Figure 2.1). Sol
solution was added to the nebulizer and connected to a compressed air supply with a
0.2μm filter. Air pressure was maintained at 40psi during vaporization using an in-line
pressure gauge. Samples were removed from chamber immediately after coating and
allowed to fully polycondensate into a solid gel for 2 minutes. Samples were covered and
stored for 3-7 days at 25°C until further use.

Figure 2.1. Schematic of vaporization chamber and formation of vaporized sol particles. Vapor
deposited sol particles are generated using H2O-tetramethyl orthosilicate (TMOS) catalyzed with HCl. (A) A
jet-type nebulizer is attached to an air compressor and feeds into a substrate chamber. (B) Applied air flow
(40psi) enters nebulizer inducing turbulent rupture of the sol, generating particles that exit the nebulizer and
deposit on to the substrate.
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Compositional Analysis
The chemical composition of the sol was determined using a series of five random
energy dispersive X-ray spectrometry (EDS) measurements. Output peaks of interest
include silicon and oxygen.
Sol Formulation and Manufacturing Parameters
The major sol formulation and manufacturing parameters affecting the vapor
particle morphology, size distribution, and degradation behavior are: H2O:TMOS molar
ratio, solution pH, deposition time, and substrate character. Molar ratios (H2O:TMOS) of
16:1 and 8:1 were used for analysis. For pH adjustments, sol solutions were adjusted to
either 1 or 6 using HCl or NaOH, respectively, before vapor deposition from an original
pH of 3. Sol particles were deposited on to non-tissue culture polystyrene (PS; VWR) for
30, 60, and 90 seconds for both H2O:TMOS and pH experiments. To investigate the
influence of substrate surface properties on particle morphology and size distribution, sol
particles were deposited onto non-tissue culture treated polystyrene (PS), tissue culture
treated polystyrene (TCPS; BD Bioscienes), and poly-L-lactide acid (PLLA;
NatureWorks) films. TCPS and PLLA were chosen as substrates due to the differences in
surface hydrophobicity (contact angle: untreated PS=73.59±1.94°, TCPS=41.08±1.91°,
PLLA= 92.49±0.22°).
Morphology and Size Distribution
Scanning electron microscopy images were used to make all particle morphology
and size distribution measurements. Samples were sputter coated with Pt/Pd and imaged
with a field emission scanning electron microscope (FE-SEM; Hitachi S-4700) under
high vacuum conditions at an accelerating voltage of 1-5kV. Quantitative measures of
particle size distribution were made using a custom written MATLAB macro. All size
distribution measurements were based on surface area measures for each individual
particle.
Degradation Behavior
The degradation behavior of the sol particle formulations was determined by
depositing particles onto non-tissue culture PS (16:1 pH 3 for 30, 60, and 90s, 16:1 pH 1
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for 60s). Silica matrix degradation over time (phenol-free Dulbecco’s Modified Eagle
Medium (DMEM; Gibco) at 37°C) was assessed using a modified colorimetric
molybdenum blue assay at 810nm. Percentage silica matrix degradation was determined
as a function of total silica deposited.
Surface Hydrophobicity and Roughness
Sol was prepared as described above and labeled with Rhodamine B (0.075µg/ml;
Molecular Probes, Invitrogen) for image analysis. To evaluate the relationship that exists
between the deposition time of particles and subsequent changes in surface properties, as
well as demonstrate the ability to easily generate a single substrate that multiple regions
of distinct surface character, a gradient was generated by vapor coating PLLA films (t=
0.5, 1, 2, 5, and 15 minutes). PLLA was chosen as a model substrate because it would
demonstrate the largest change in surface character with the deposition of sol particles
due to its hydrophobic character. Samples were imaged using fluorescent microcopy,
covered, and stored at room temperature until further analysis. The effect of vapor
deposition on substrate surface hydrophobicity was determined using standard contact
angle methods (sessile drop method). A Kruss G10 goniometer (Rame-Hart, Inc.) system
was used to make all measurements. Droplets of di-H2O were added to the center of each
sample; angle measurements at the liquid/substrate surface interface were taken and
droplets were added until a plateau was reached (approximately 3-12µl total). All
measurements were taken at 25°C.
Comparative surface roughness of the PLLA film coated with a gradient of
particles was determined using atomic force microscopy (AFM). A Nanoscope E (Digital
Instruments) AFM system (constant deflection mode) with a micro-fabricated silicon
nitride cantilever was used for imaging in air with a 5µm scanner. The surface
topographical images of the PLLA film coated with vapor particles obtained by AFM
were processed using Digital Instruments AFM software. RMS roughness (Rq) of the
surface, defined as the standard deviation of the elevation (z values) within the given
area, was determined within the image area (2.5µm). Images were taken at six different
locations and the average RMS roughness was determined based on these images.
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Measurements were taken at regions corresponding to 0.5, 1, and 2 minute deposition
times on a sol gradient.
Cell Attachment
Samples were generated by depositing sol solution (16:1 H2O:TMOS; pH 3) for
60 and 90 seconds on to non-tissue culture PS. Samples were sterilized using ethylene
oxide and rinsed three times with sterile phosphate buffered saline (PBS). MC3T3-E1
Subclone 4 osteoblast progenitors (ATCC) were cultured directly on plates coated with
particles or non-tissue culture PS as a control (1x104 cells/cm2) at 37°C and 5% CO2 in
Minimal Essential Media (α-MEM; Hyclone) supplemented with 1% penicillinstreptomycin (Mediatech) and 10% fetal bovine serum (FBS; Hyclone). Cells were also
cultured on non-tissue culture PS using media that had been conditioned for 48 hours
with particles deposited for 90 seconds at 37°C and 5% CO2.
At 24 and 48 hours, cells were fixed (4% paraformaldehyde), stained (TRITCconjugated Phalloidin and 4',6-diamidino-2-phenylindole, DAPI; Molecular Probes,
Invitrogen), and imaged (Olympus BX51 microscope). Cell attachment was determined
through direct cell counts and normalized to control samples with untreated media. To
determine whether particle degradation affected culture media with time, pH
measurements were made at both 24 and 48 hours.
Statistics
All experiments were performed in triplicate. Data was analyzed for significance
using an analysis of variance (ANOVA) and a Tukey’s post-hoc test for pairwise
comparison. Statistical significance defined as a p-value less than 0.05 (p<0.05). Error
bars in text and graphs represent standard error of the mean (±SEM).
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RESULTS
Effect of Formulation and Manufacturing Parameters on Particle Morphology and
Size Distribution
H2O:TMOS MOLAR RATIO
Silica nano- and micro-particles were generated using the vaporization chamber.
EDS analysis of the particles showed a percent atomic composition of 43.47±1.76 silicon
and 54.88±1.30 oxygen with trace amounts of carbon registering from the underlying
polystyrene plate. The effect of H2O:TMOS molar ratio on sol particle morphology and
size distribution was determined. Particles were generated from solutions with
H2O:TMOS molar ratios of 16:1 or 8:1 (pH 3), deposited onto PS for 30, 60, and 90
seconds, and imaged using FE-SEM (Figure 2.2A). At a molar ratio of 8:1 average
particle area (µm2) did not change significantly with deposition time [0.136±0.01 t=30s,
0.114±0.01 t=60s, 0.130±0.02 t=90s; p≥0.5] and the particle size distributions (Figure
2.2B) were also consistent for all deposition times. At a molar ratio of 16:1 the average
particle area (µm2) changed significantly with time [0.620±0.13 t=30s, 0.076±0.01 t=60s,
0.329±0.06 t=90s; p<0.0001] and the size distributions (Figure 2.2C) also varied with
deposition time. At each deposition time the average particle area for the 8:1 and 16:1
particles was significantly different; the average area was larger for 16:1 particles at 30
and 90 seconds (p<0.0001) and 8:1 particles at 60 seconds (p<0.002; Figure 2.2D).
SOL PH
To investigate the effect of pH on particle morphology and size distribution, the
pH of sol solutions (16:1 H2O:TMOS) was adjusted from 3 to 1 or 6 before vapor
deposition onto PS for 30, 60, and 90 seconds. FE-SEM images show particle
morphologies at 30, 60, and 90 seconds (Figure 2.3A). Particles generated from solutions
with an unadjusted pH 3 had average particle areas (µm2) [0.620±0.13 t=30s, 0.076±0.01
t=60s, 0.329±0.06 t=90s; p<0.0001] and size distributions (Figure 2.3B) that varied at
each deposition time. Particles generated from solutions with an adjusted pH of 1 had
average particle areas (µm2) and size distributions (Figure 2.3C) that were similar
regardless of deposition time, with the average particle area being significantly smaller at
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90 seconds than the average area at 60 seconds [0.052±0.01 t=30s, 0.058±0.004 t= 60s,
0.040±0.001 t=90s; p<0.0001]. Though the average area (µm2) of particles generated
from pH 6 solutions increased with deposition time, these changes were not statistically
significant [0.133±0.05 t=30s, 0.296±0.08 t=60s, 0.339±0.07 t=90s; p=0.1] and particles
were much more irregular in shape than those generated from solutions with pH equal to
1 or 3 (Figure 2.3A). The size distributions of the pH 6 particles also varied with
deposition time (Figure 2.3D). At 30 seconds the average particle area was significantly
different for all three particle formulations with pH 1 particles being smallest and pH 3
particles being largest (p<0.02). At 60 seconds, pH 1 and 3 particles were significantly
smaller than pH 6 particles (p<0.0001), and at 90 seconds the average particle area of pH
1 particles was significantly smaller than pH 3 and pH 6 particles (p<0.0001; Figure
2.3E).
SUBSTRATE
The effect of substrate surface properties on particle morphology and size
distribution was also investigated (16:1 H2O:TMOS, pH 3). In addition to PS, particles
were deposited onto TCPS and PLLA (Figure 4A). Particles deposited onto TCPS had
average particle areas (µm2) that were significantly smaller at 60 seconds than 30 or 90
seconds [0.123±0.02 t=30s, 0.044±0.01 t=60s, 0.104±0.02 t=90s; p<0.01]. The size
distribution of particles deposited onto TCPS also varied with deposition time (Figure
2.4C). Particles deposited onto PLLA maintained a similar size distributions regardless of
deposition time (Figure 2.4D),

though the average particle areas (µm2) were

significantly different from each other at each deposition time [0.138±0.02 t=30s,
0.049±0.002 t=60s, 0.083±0.01 t=90s; p<0.0001]. Similar to particles deposited onto PS,
particles on TCPS and PLLA had largest average particle areas at 30 seconds, a decrease
in size at 60 seconds and a subsequent increase at 90 seconds. At 30 and 90 seconds the
average area of particles deposited onto PS was significantly larger than that of particles
deposited on to TCPS or PLLA (p<0.0001). At 60 seconds the average particle size was
not significantly different on any of the substrates (p=0.6; Figure 2.4E).
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Figure 2.2. Effect of H2O:TMOS on particle morphology and size distribution. Sol solutions (pH 3) with H2O:TMOS of 8:1 and 16:1 were vapor deposited
on to PS for 30, 60, and 90 seconds, (A) imaged using FE-SEM (scale bar = 10µm) and the area-based size distribution of particles was analyzed using a
MATLAB macro [(B) 8:1 (C) 16:1]. (D) Average particle area did not change with increasing deposition time for 8:1 particles. Average area of 16:1 particles was
initially largest, decreased at 60 seconds followed by an increase at 90 seconds. A molar ratio of 16:1 produced larger particles at 30 and 90 seconds while at
60 seconds a ratio of 8:1 yielded relatively larger particles. All comparisons were made using ANOVA, p-values < 0.05 were considered significant. Values with
different letters/numbers are significantly different-- letters compare different deposition times in same group (rows) and numbers compare different groups
within same deposition time (columns). Error bars represent ±SEM.
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Figure 2.3. Effect of solution pH on particle morphology and size distribution. The pH of sol solutions (16:1 H2O:TMOS) was adjusted from 3 to 1 or 6,
deposited on to PS for 30, 60, and 90 seconds, (A) imaged using FE-SEM (scale bar = 10µm), and the area-based size distribution was analyzed using a
MATLAB macro [(B) pH 3, (C) pH 1, (D) pH 6]. (E) Particles generated from a solution with a pH of 3 produced the largest average particles at 30 seconds with
a decrease in particle area at 60 seconds and an increase at 90 seconds. Solutions with a pH 1 generated particles with average areas that decreased at 90
seconds. Average particle area did not change in pH 6 particles regardless of deposition time. At 30 seconds, pH 1 particles generated the smallest average
particles and pH 3 the largest. At 60 seconds, pH 6 particles were larger than pH 1 and pH 3 particles, and at 90 seconds the average area of pH 1 particles is
smaller than pH 3 and pH 6 particles. All comparisons were made using ANOVA, p-values < 0.05 were considered significant. Values with different
letters/numbers are significantly different-- letters compare different deposition times in same group (rows) and numbers compare different groups within same
deposition time (columns). Error bars represent ±SEM.
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Figure 2.4. Effect of substrate on particle morphology and size distribution. Sol solutions (16:1 H2O:TMOS; pH 3) were deposited on to PS, TCPS, and
PLLA for 30, 60, and 90 seconds, (A) imaged using FE-SEM (scale bar = 10µm), and the area-based size distribution was analyzed using a MATLAB macro
[(B) PS, (C) TCPS, (D) PLLA]. (E) Analysis of the average particle area showed that on all substrates at 30 seconds deposition time, the average particle area
was largest, with a decrease in average particle area at 60 seconds and a subsequent increase in particle area at 90 seconds. The average particle area of
particles deposited on to PS was larger than those deposited onto TCPS and PLLA at all deposition times. All comparisons were made using ANOVA, p-values
< 0.05 were considered significant. Values with different letters/numbers are significantly different-- letters compare different deposition times in same group
(rows) and numbers compare different groups within same deposition time (columns) Error bars represent ±SEM

Effect of Formulation Parameters on Particle Degradation Behavior
The effect of deposition time and solution pH on particle degradation behavior
was determined. Particles with a pH 3 (16:1 H2O:TMOS) were deposited onto PS 30, 60,
and 90 seconds or an adjusted pH of 1 for 60 seconds. The amount of silica degraded
over time in DMEM at 37°C was determined as a function of total silica deposited using
a colorimetric silica assay. Though the amount of silica deposited (mg/cm2) onto the plate
increases with deposition time the changes are not significant (p=0.07; Figure 2.5B).
Particles deposited for 30 seconds (pH 3) were fully degraded by day 4 and pH 1 60s
particles by day 5, while pH 3 60s and pH 3 90s particles were 97.38±2.62% and
98.84±1.16% degraded, respectively by day 10. The percent degradation for pH 3 30s
particles was significantly higher than pH 3 60s particles for days 1-3 and pH 3 90s
particles at days 1 and 2 (p<0.04). Particles with an adjusted pH of 1 (60s) degraded
significantly faster than pH 3 60s particles during the first two days only (p=0.04; Figure
2.5A).

Figure 2.5. Effect of deposition time and pH on degradation of sol particles. Sol solutions with
H2O:TMOS of 16:1 were vapor deposited onto PS for 30, 60, and 90 seconds. Additionally particles with
an adjusted pH of 1 were vapor deposited onto PS for 60 seconds. (A) Silica matrix degradation over time
in phenol-free DMEM at 37°C was determined by measuring dissolved Si(OH)4 using a modified
molybdenum blue assay at 810 nm. pH 3 30s particles were fully degraded by day 4 and pH 1 60s
particles were fully degraded by day 5, while at day 10 pH 3 60 and 90s particles were 97.38±2.62% and
98.84±1.16% degraded, respectively. Percent degradation of pH 3 30 second and pH 1 60 second
particles was significantly different than pH 3 60s and 90 second particles during the first three days. (B)
2
Total silica content on the plates (mg/cm ) shows an increase in silica deposited onto places increasing
with deposition time. All comparisons were made using ANOVA, p-values < 0.05 were considered
significant (* indicates statistical significance). Error bars represent ±SEM.
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Effect of Particle Deposition on Substrate Surface Character
Contact angle analysis was used to determine changes in surface hydrophobicity
with increasing sol deposition (Figure 2.6B). The average contact angle significantly
decreased with increasing vapor deposition time [92.49±0.22° at t=0 to 73.92±1.33° at
t=15min; p<0.0001]. The overall trend showed that increasing vapor deposition caused a
decrease in contact angle, indicating that the surface hydrophobicity decreases with vapor
deposition time [88.38±1.13° t=1min, 81.11±0.82° t=2min]. However, the contact angle
did increase at 5 minutes (85.68±1.51°) before decreasing again. Surface roughness
measurements on sol gradient showed that average surface roughness (RMS roughness)
increased with increased vapor deposition time [0.22±0.05nm at t=0 to 303.4±42.83nm at
t=2min; Figure 2.6C]. There were significant increases in surface roughness at
deposition times of 1 and 2 minutes when compared to the uncoated PLLA films
(p<0.003). Roughness measurements at deposition times greater than 2 minutes were not
feasible due to the resolution limits of AFM roughness measurements.
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Figure 2.6. Effect of sol particles on surface wettability and roughness. (A) A sol gradient was generated on a PLLA film using a simple masking approach
with vaporization time of Rhodamine B labeled sol ranging from 1-15 minutes and imaged using fluorescent microscopy. (B) Sessile drop contact angle analysis
on a sol gradient was used to determine the relative hydrophobicity change on PLLA substrate with increasing particle deposition. The contact angle measures
showed a general decrease with increasing vapor deposition indicating the surface hydrophobicity is decreasing. (C) Comparative surface roughness changes
along gradient using AFM micrographs and analysis of 2.5μm area showed an increased surface roughness with increasing deposition time. Measurements over
two minutes were not possible using AFM approach. All comparisons were made using ANOVA, p-values < 0.05 were considered significant. Values with
different letters are significantly different. Error bars represent ±SEM.

Osteoblast Response to Sol Particles
MC3T3 preosteoblasts were cultured on non-tissue culture PS dishes that were
coated with particles (16:1 H2O:TMOS; pH 3) for 60 (Figure 2.7C,G), 90 seconds
(Figure 2.7D,H), and on plain non-tissue culture PS dishes using either untreated culture
media (Figure 2.7A,E) or culture media that had been conditioned for 48 hours with
particles deposited for 90 seconds (Figure 2.7B,F) for 24 or 48 hours. At 24 hours, cell
attachment on substrates cultured with conditioned media and those coated with sol
particles for 60 and 90 seconds showed higher attachment compared to the control
cultures, with significantly higher attachment on 90s cultures [attachment=1.00±0.16
control, 1.57±0.24 conditioned media, 1.59±0.22 t=60s, 1.97±0.29 t=90s; p=0.03]. At 48
hours, cell attachment on substrates using conditioned media and those coated with sol
particles for 60 and 90 seconds was still higher than control cultures with significantly
higher attachment at 60s [attachment=1.00±0.11 control, 1.34±0.11 conditioned media,
1.88±0.24 t=60s, 1.37±0.15 t=90s; p=0.002; Figure 2.7I]. To determine whether the sol
particles affected media pH during culture as the particles degraded and released ions,
media pH was recorded at each time point. No significant differences were found
between the pH of control culture media and those of conditioned media or cultures
containing particles (p=0.2; data not shown).
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Figure 2.7. Osteoblast response to sol particles. MC3T3 preosteoblasts were cultured on non-tissue culture PS dishes that have been vapor coated with
sol particles (16:1 H2O:TMOS; pH 3) for (C,G) 60 or (D, H) 90 seconds or on plain non-tissue culture PS dishes using either (A,E) untreated culture media or
(B,F) culture media that had been conditioned with particles (deposited for 90 seconds) for 48 hours. At (A-D) 24 and (E-H) 48 hours the cells were stained
using TRITC-conjugated Phalloidin and DAPI and cell attachment was assessed (scale bar = 200µm). (I) Cell attachment on plates coated with sol particles
had higher attachment at both 24 and 48 hours compared to control cultures that used untreated culture media (significant differences 60 seconds at 24 hours
and 90 seconds at 48 hours). All comparisons were made using ANOVA, p-values < 0.05 were considered significant (* indicates statistical significance). Error
bars represent ±SEM.

DISCUSSION
There are inherent limitations in current techniques for the surface modification of
biomaterials; this work focused on the development of a simple, rapid, and effective
method to generate silica particles for the surface modification of biomaterials without
extreme processing conditions (i.e. high temperatures and pressures and harsh solvents)
used in other sol-gel manufacturing methods. Particle morphology, size distribution, and
degradation behavior was characterized, and controlled by adjusting key manufacturing
parameters including H2O:TMOS molar ratio, pH, deposition

time, and substrate.

Changes in surface properties (hydrophobicity and roughness), the ability to incorporate
apatite specific ions, and cell behavior in response to particles was also determined.
The amount of water available for the hydrolysis reaction has a dramatic influence
on gelation time of a sol-gel solution. For lower water contents (H2O:TMOS<7-8:1) an
increase in the amount of water available decreases the gelation time. At H2O:TMOS>78:1, the increase in water creates a dilution effect, with the gelation time increasing with
the quantity of water [17, 34]. Molar ratios of 8:1 and 16:1 were used to determine the
effect on particle morphology and size distribution. Solutions with an 8:1 ratio produced
particles that were consistently the same size (size distributions and average particle size)
regardless of deposition time. Solutions with a 16:1 ratio produced particles whose
average area peaked at 30 seconds; decreased at a deposition time of 60 seconds and
subsequently increased again at 90 seconds. The size distributions of the 16:1 particles
showed similar trends at each deposition time. These differences may be attributed to
gelation behavior. In 8:1 particles, deposition time was found to be irrelevant, whereas in
the 16:1 particles, deposition time has an effect on the average particle size and
distribution. Elevated relative water content may increase the gelation time of particles,
causing deposition time to play a larger role in resultant particle size, with solutions
containing a lower water content, whose gelation rates would be faster.
It is widely accepted that the polymerization of sol-gels is highly pH dependant.
In the polymerization reaction the point of zero charge (where the surface charge is zero)
and the isoelectric point (the point where the electrical mobility of the silica particles is
zero) fall between pH 1 and 3, producing slower gelation times. Between pH 2 and 6 the
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gelation rate is proportional to the concentration of OH-, steadily decreasing the gelation
time with increasing pH. Solutions become most unstable (and therefore gelling most
quickly) at pH 5-6. Below pH 2, where the solubility of silica is low, solutions are
considered metastable resulting in gelation times that are relatively long and
polymerization rates are proportional to the concentration of H+ [17, 34]. The original pH
of the sol gel solutions was 3. Adjustments of the solution to pH 1 and 6 were chosen due
to the limitations of the system: at pHs lower than 1 solutions did not gel at all and at pHs
higher than 6 solutions gelled too quickly to be used in the nebulizer. Solutions with a pH
of 3 were stable enough to be used in the vaporization system but gelled quickly enough
that deposition time influenced particle size. Particles generated from pH 1 solutions
produced particles with very small average particle sizes and similar size distributions at
all times points. This is most likely due to the low viscosity and long gelation time of the
colloidal solution. Solutions with a pH of 6 produced particles that had irregularly shaped
morphologies and particles sizes that were inconsistent from sample to sample due the
rapid gelling rate of the solution. The rate of polymerization of a sol solution is dependent
upon the pH and therefore will have the largest impact on particles at pH values between
2 and 6, where the gelation rate of the solution is the most suitable for use in the
deposition system.
The underlying substrate will always play a role in dictating the outcome of any
surface modification approach, due to substrate surface chemistry, hydrophobicity
(wettability), and roughness. Particles were vapor deposited onto three distinct substrates
(PS, TCPS, PLLA) to demonstrate this. On all substrates, particles show a trend with an
average area largest, decreasing, and then subsequently increasing again at 30, 60, and 90
seconds deposition time, respectively. However, at all three deposition times the average
particle area was always significantly larger on PS than on TCPS or PLLA. A fraction of
the particles deposited on to PS were able to aggregate and form larger particles before
gelation, resulting in larger average particle areas. Plasma treatment of polystyrene
(TCPS) decreases the hydrophobicity of the surface (contact angle of 41.08±1.91°
compared to 73.59±1.94° of untreated PS), and generates a surface containing more
exposed oxygen groups. This may allow for better adsorption of proteins such as
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vitronectin, providing a surface that is more conducive to cell attachment than untreated
PS.[37-39] This change in surface chemistry interacts with the sol particles, which
generates smaller particles than on PS. The highly hydrophobic nature of the PLLA
surface (contact angle 92.49±0.22°) may essentially isolate the hydrophilic sol particles
as they are deposited onto the PLLA surface preventing them from aggregating before
they gel, resulting in many small particles at all deposition times [40]. The surface
properties of a substrate will help dictate the particle size due to the interactions between
the substrate and the particles.
The duration that cells are exposed to a material will determine to what extent it
will influence their behavior. Therefore, the degradation rate of a material will
significantly impact its overall effectiveness as an instrument to direct cell behavior. The
degradation behavior of particles generated from 16:1 pH 3 (deposition time 30, 60, and
90s) and 16:1 pH 1 (deposition time 60s) solutions was determined over 10 days.
Particles deposited for 30s degraded most quickly, most likely due to the increased
effective surface area available for degradation, compared to those deposited for 60 or
90s when particles have time to aggregate and thereby reducing the effective surface area.
pH 1 60s particles also degraded more quickly than their pH 3 counterparts even though
the silica content on the plates was similar. This is could be due to the differences in the
networking in the pH 1 particles during the extended gelation time. The differences in
degradation between particle groups are largest within the first three days, indicating that
particles will have the greatest impact on cell behavior during this time period. Substrate
surface character can impose a strong influence on initial protein adhesion, cell viability
and attachment (nanoseconds to days), and consequently influence long-term cell
behavior including cell spreading, proliferation, differentiation, and extracellular matrix
production [41].
The surface properties of a material can be used to direct many aspects of cell
behavior including attachment, proliferation, and differentiation depending on the cell
type. Specifically, osteoblasts and osteoblast precursors have been found to respond to
surface hydrophobicity in a time dependant manner. Initial cell attachment and spreading
have been found to be higher on moderately hydrophilic surfaces than on hydrophobic
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surfaces [42]. In general, osteoblasts have better adhesion, larger cell spreading, higher
proliferation, and enhanced differentiation on substrates with an increased surface
roughness. Many studies have shown that surface roughened implants promote
osseointegration better than their smooth counterparts [43, 44]. In this work it was
demonstrated that increasing vapor deposition of particles onto substrates caused a
decrease in contact angle, indicating that the surface became more hydrophilic. Vapor
deposition of sol particles also showed the ability to increase the surface roughness of a
material. Furthermore, a unique surface topography is created when sol is deposited onto
substrates. This random surface topography generated by the deposition of sol particles
onto substrates may further help to promote osteoblast differentiation. Dalby et al.
showed that mesenchymal stem cells cultured on substrates containing nano-pit arrays
differentiate into either fibroblasts or osteoblasts depending on the order/disorder of the
arrays. Cells cultured on highly ordered arrays resulted in cells with fibroblastic
appearances, while cells cultured on more irregular arrays resulted in cells with an
osteoblastic morphology and gene expression [45]. Vapor deposited sol particles allow
for the modification of a material’s surface properties in a way that could aid in directing
osteoblast behavior by increasing surface hydrophilicity and roughness, as well as
generating a unique surface topography.
The ultimate goal of this work is to be able to use these particles in combination
with other conventional biomaterials such as orthopedic and dental implants and tissue
engineering scaffolds to better direct cell behavior including attachment, proliferation,
and differentiation via cell-material interactions. Vapor deposition of sol particles onto
non-tissue cultures PS substrates increased attachment of preosteoblasts in comparison to
controls cultured on PS alone, potential indication their ability to increase cell
proliferation. Cells cultured with no particles and media that had been conditioned with
particles (containing silica sol dissolution products) also showed increased cell
attachment, though the effect was not significant (p=0.45). This indicates that increases in
cell attachment can be attributed in part to both the modification of the physical
properties of the PS (wettibility, roughness, topography) as well as the chemical
composition, specifically silica. It is important to note that degradation products did not
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significantly change pH in culture. This surface modification method allows for the
deposition of particles whose chemical and physical properties cause an increase in cell
attachment onto substrates, indicating the potential of further directing osteoblast
behavior.
CONCLUSION
This work demonstrates the use of a simple and novel system for the surface
modification of materials through the vapor deposition of silica sol-gel particles. The
morphology, size distribution, and degradation of these particles can easily be controlled
through key formulation and manufacturing parameters including sol H2O:TMOS molar
ratio and pH, as well as deposition time and substrate character. These particles can be
used to alter the overall surface properties of a material including surface hydrophobicity,
roughness, and topography. Furthermore, these particles increase initial cell attachment
of preosteoblasts compared to unmodified control substrates, demonstrating their
potential to aid in promoting cell attachment. Current work is focused on how different
formulations of particles can promote osteoblast attachment, proliferation, and
differentiation using quantitative gene expression measures.
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CHAPTER THREE: CALCIUM-PHOSPHATE
SILICA SOL PARTICLES FOR BIOACTIVE
SURFACE MODIFICATION 2
This chapter expands on the methods for generating vapor deposited particles developed
in Chapter 2 by incorporating biologically active elements, calcium and phosphate ions,
into the particles. The work in this chapter addresses Specific Aim 2.
INTRODUCTION
Bioactive glasses and other silica based materials are becoming increasingly
popular for use in biomedical applications due to their inherent biocompatibility; ability
to actively influence cell driven processes including osteogenesis and angiogenesis; and
enhanced antimicrobial character [4]. These glasses can be generated using a variety of
methods, with two of the most common being melt derived and sol-gel processing. Solgel approaches have an advantage over traditional melt methods because they allow for
mild processing conditions (ambient temperature-pressure and biologically tolerated byproducts) and simple methods to control composition and structure of the material.
Because of this sol-gel based materials have been used as delivery vehicles for various
inorganic and organic small molecules including ions, drugs, enzymes, antibodies,
growth factors, DNA, and even cells [7, 89-95].
The main disadvantage of sol–gel synthesis over the melt process is that it is
difficult to obtain crack-free bioactive glass monoliths (diameters >1 cm) due to cracking
during drying. The cracking can result in part from the large shrinkage that occurs during
drying; and the evaporation of the liquid by-products of the condensation reaction.
During drying, vapor must travel from within the gel to the surface via the interconnected
pore network. This can cause capillary stresses within the pore network and therefore
cracking. For small cross-sections, such as in particles, drying stresses are small, as the
path of evaporation is short and the stresses are accommodated. For monolithic objects,
the path from the center of the monolith to the surface is long and tortuous, and the
1

The material presented in this chapter is in preparation for submission to the Journal of Biomedical
Materials Research Part A. [Snyder KL, Holmes HR, Rajachar RM].
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drying stresses can introduce catastrophic fracture. Increasing pore size and obtaining
pores with a narrow distribution reduce tortuosity [107].
When exposed to body fluids bioglass materials generate a dynamic bio-reactive
surface microenvironment that can act as a strong bonding interface between the glass
and a hard or soft tissue environment. Upon exposure, soluble silica in the form of
Si(OH)4 is lost in solution, breaking Si-O-Si bonds and creating Si-OH (silanols) at the
material-solution interface. SiO2 condensates and re-polymerizes at this surface, causing
the migration of Ca2+ and PO43- --forming a CaO—P2O5 rich film at the SiO2–aqueous
interface. This amorphous CaO—P2O5 film continues to grow incorporating calcium and
phosphate from solution, which is then crystallized by incorporation of OH- and CO32anions to form a mixed hydroxyapatite (HA) layer. At this point biological growth factors
can adsorb into the HA layer, contributing to activate differentiation of stem cells into
osteoblasts (Table 3.1-see also Figure 1.6). This dynamic interaction creates a strong
bonding interface between the glass and its hard or soft tissue environment. In hard
tissues a bond is formed due to the biological equivalence of the mineral phase of bone
and the growing HA layer of the bioglass material. Soft tissue bonding occurs when
collagen fibrils are chemisorbed on the SiO2 layer by electrostatic, ionic, and/or hydrogen
bonding and HA is precipitated and crystallized onto collagen fibers and material
surfaces [87].
Table 3.1. Overview of apatite formation on bioglass material upon exposure to body fluids.
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The HA layer that is formed at the sol-gel glass surface is dependent upon many
factors including the ion concentration and pH of the solution medium as well as the
composition of the sol material and its physical properties (i.e. roughness, topography,
surface area, pore size) [138-142]. Recent work has been focused on determining the
effect of additional elements (including calcium, phosphate, magnesium, potassium,
aluminum, cobalt, boron, vanadium, zinc, strontium, iron and fluorine) to the
composition of the bioglass and bioactivity, with the majority of the focus being on the
addition of calcium and phosphate to the silica network. These elements are known
network modifiers to the architecture of the silica network, and consequently the
composition of mineral phase (Figure 3.1) [113, 114, 142, 143]. High calcium content in
bioglass has been found to increase pore volume and decrease surface area of the
material, thus increasing the amount of calcium released, which leads to increased apatite
formation [141, 144-146]. While phosphate is not necessary in glasses for apatite
formation, when the amount of P2O5 is added in less than 6 mol%, it increases the surface
area and decreases pore diameter and pore volume, as well as induces mineral crystal
growth more quickly than glasses without it [144, 147-149]. However, the composition
of a sol-gel glass that is optimum for mineral formation is not known and remains a topic
of exploration [4, 113, 114].
The goal of this work was to successfully incorporate calcium and phosphate ions
into vapor deposited silica sol-gel particles (three different formulations). The
morphology and size distribution of the calcium-phosphate sol particles was determined
as well as how these particles affected overall substrate hydrophobicity. The silica matrix
degradation and ion release character was also determined. Finally, the ability for these
particles to induce apatite mineral formation was determined.
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Figure 3.1. Network modifiers. Incorporation of additional ions (i.e., calcium, phosphate magnesium,
potassium) into a sol-gel will modify the silica network architecture and therefore have a resulting effect on
the composition of the mineral formed.

MATERIALS AND METHODS
Sol Preparation and Vapor Deposition
The base compositions of the sol solutions used in these experiments was a 16:1
molar ratio of de-ionized water to tetramethyl orthosilicate (TMOS; Sigma Aldrich). The
solution was catalyzed with 0.04M hydrochloric acid (HCl; Sigma Aldrich) at 2μl per
gram of TMOS/di-H2O. Catalyzed solutions were agitated for 20 minutes to ensure that
the solution was completely mixed. The clear homogenous solution was then allowed to
rest for 30 minutes at 25°C, where the solution was then stable for vaporization.
Nebulizer-based vaporization was carried out using a jet-type nebulizer (Pari LC Plus,
Allegro Medical) attached to a 500ml polycarbonate bottle whose bottom had been
removed and served as the vaporization chamber. The nebulizer containing the sol was
connected to a compressed air supply with a 0.2μm airline filter. Sol was vapor deposited
onto non-tissue culture polystyrene (PS) for 60 seconds at 40psi, maintained using an in65

line pressure gauge. Samples were removed immediately after deposition and the sol was
allowed to fully polycondensate into a solid gel for 2 minutes. Samples were covered and
stored at 25°C for 3-7 days until further use.
Calcium and Phosphate Incorporation into Sol
Calcium (Ca) and phosphate (P) ions were incorporated into solutions just before
vapor deposition by adding 1M calcium chloride (CaCl2; Sigma Aldrich) and 1M triethyl
phosphate (TEP; Sigma Aldrich) in three different formulations (v/v%): 5% Ca/5% P,
25% Ca/25% P, and 25% Ca/5% P.
Size Distribution and Morphology
Scanning electron microscopy was used to characterize the morphology and size
distribution of the sol particles. All samples were sputter coated with Pt/Pd (5nm) and
imaged with a field emission scanning electron microscope (FE-SEM; Hitachi S-4700)
under high vacuum conditions at accelerating voltages of 1-5 kV. Quantitative measures
of particle size distribution were made using a custom written MATLAB macro. All size
distribution measurements were based on surface area measures for each individual
particle.
Surface Hydrophobicity
The effect of vapor deposition of Ca/P sol particles on substrate surface
hydrophobicity was determined using standard contact angle methods (sessile drop
analysis) at 25°C. A Kruss G10 goniometer (Rame-Hart, Inc.) system was used to make
all measurements. Droplets of di-H2O were added to the center of each sample in
succession; angle measurements at the liquid/substrate surface interface were taken and
droplets were added until a plateau was reached (approximately 3-12µl total).
Degradation Behavior
The degradation behavior of the silica matrix over 7 days in phenol-free media at
37°C was determined using a modified colorimetric tin chloride-molybdenum blue silica
assay at 810nm. Percentage silica matrix degradation was determined as a function of
total silica deposited.
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Mineral Composition and Morphology
Ca/P particle ability to induce stabile mineral crystal formation was assessed by
vapor depositing sol solutions onto PS plates for 60 seconds and incubating in simulated
body fluid (SBF) at 37°C for 7 days. Control groups consisted of PS plates containing no
particles and PS plates coated with sol particles containing no calcium or phosphate for
60 seconds. SBF solutions were changed every 2 days to replenish ions. Mineral crystal
morphology and composition were analyzed with FE-SEM imaging and using energy
dispersive X-ray spectrometry (EDS) compositional analysis, respectively. Output peaks
of interest included calcium and phosphate and the calcium to phosphate ratio (Ca:P) of
the mineral was determined.
3-D Application of Vapor Deposition Methods
To demonstrate the practical application of these particles for use in orthopedic
tissue engineering applications, 5Ca/5P particles were vapor deposited onto model 3-D
porous fibrin scaffolds used for orthopedic tissue engineering [40, 50, 150] for 90
seconds Figure 3.2). Control groups consisted of fibrin scaffolds not coated with sol
particles and fibrin scaffolds coated with particles containing no calcium or phosphate for
90 seconds. Fibrin scaffolds were generated by sintering 200µm diameter poly(methyl
methacrylate) (PMMA; Polysciences Inc.) spheres at 145°C for 22 hours to generate
molds. The molds were then immersed in a fibrinogen solution (200mg/ml in 0.9% NaCl;
Sigma-Aldrich) and vacuum infiltrated overnight. The fibrinogen infiltrated molds were
then cross-linked in a thrombin (Biopharm Laboratories) solution and the PMMA beads
were dissolved from the scaffolds by soaking them in acetone for 72 hours. Mineral
crystal formation was induced on the vapor coated scaffolds by incubating them in
simulated body fluid (SBF) at 37°C for 7 days. SBF solutions were changed every 3 days
to replenish ions. Mineral crystal morphology and composition were analyzed with FESEM imaging and EDS compositional analysis, respectively.
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Figure 3.2. Application of vapor deposition methods. (A) Scaffold preparation: sphere-templated fibrin
scaffolds were generated by vacuum infiltrating fibrinogen into a mold of sintered PMMA spheres, crosslinking the fibrinogen with a thrombin solution and removing the PMMA spheres in acetone to create porous
scaffolds. (B) Vapor-directed mineralization: porous fibrin scaffolds were placed in vaporization chamber and
vapor coated with 5Ca/5P particles for 90 seconds. Vapor coated scaffolds were then immersed in SBF for 7
days. Methods for coating and inducing mineral growth on 2-D materials are similar to that seen in (B)

Statistics
All experiments were performed in triplicate (n=3) unless otherwise stated. Data
was analyzed for significance using an analysis of variance (ANOVA) and a Tukey’s
post-hoc test for pairwise comparison. Statistical significance defined as a p value less
than 0.05 (p<0.05). Error bars in text and on graphs represent standard error of the mean
(±SEM).
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RESULTS
Size Distribution and Morphology
The size distribution and morphology of particles loaded with calcium and
phosphate and vapor deposited onto PS for 60 seconds was assessed. A deposition time
point of 60 seconds was chosen because of the results seen in work up to this point
showed similar effects to that of particles deposited for 90 seconds. The average area of
25Ca/25P particles were significantly larger (0.24±0.02µm2) than both 5Ca/5P
(0.12±0.02µm2) and 25Ca/5P (0.13±0.01µm2) particles (p<0.001) and were much more
irregularly shaped (Figure 3.3A). The size distributions of the particles is similar for
5Ca/5P and 25Ca/5P particles but 25Ca/25P particles had a much larger fraction of
particles that were ≤0.0025µm2 (5Ca/5P = 0.17±0.01; 25Ca/25P = 0. 67±0.02; 25Ca/5P =
0.18±0.01; Figure 3.3B).

Figure 3.3. Morphology and size distribution of vapor deposited Ca/P sol particles. (A) SEM images
show morphology of 5Ca/5P, 25Ca/25P, and 25Ca/5P particles vapor deposited for 60 seconds onto
polystyrene. (scale bar = 10µm). Average area of particles was determined using an area-based MATLAB
macro and 25Ca/25P particles were found to be significantly larger than both 5Ca/5P and 25Ca/5P particles.
All comparisons were made using ANOVA, p-values < 0.05 were considered significant. Values expressed
as ±SEM.
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Surface Hydrophobicity
Deposition of 25Ca/25P and 25Ca/5P particles each significantly decreased the
contact angle measurement (50.5±1.2° and 66.3±1.4° respectively) of the surface when
compared to the PS plate controls (79.7±1.9°) and those coated with 5Ca/5P particles
(74.4±1.1°), indicating that deposition of these particles makes the overall surface
character more hydrophilic (p<0.04; Figure 3.4). Comparatively, the contact angle of
TCPS, which has been plasma treated to allow for optimal cell attachment is 41.08±1.91°
and PLLA, which is a highly hydrophobic, has a contact angle of 92.49±0.22°.
Deposition of Ca/P sol particles lowers the contact angle to closer to that of TCPS.

Figure 3.4. Surface hydrophobicity of vapor deposited Ca/P sol particles. (A) 25Ca/25 P particles have
larger, more irregularly shaped particles that have a higher substrate surface coverage than 5Ca/5P and
25Ca/5P particles. (B) Contact angle analysis shows that depositing Ca/P sol particles for 60 seconds
decreases the contact angle of the substrate surface.

Particle Degradation
The degradation behavior of the Ca/P sol particles in media at 37°C was found to
be similar for all formulations except for at day 1 where Ca5/5P (56.1±4.3%) particles
were significantly less degraded than 25Ca/25P (86.1±10.7%; p=0.03) and 25Ca/5P
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(90.1±4.2%; p=0.048) particles, with all particles being over 90% degraded at day 7
(Figure 3.5A). Deposition of 25Ca/25P particles for 60 seconds led to significantly more
total silica (0.014±0.003 mg/cm2) being deposited onto the substrate than for 5Ca/5P
(0.025±0.003 mg/cm2; p=0.04) and 25Ca/5P (0.010±0.001 mg/cm2; p=0.01) particles
(Figure 3.5B).

Figure 3.5. Ca/P sol particle degradation behavior. The degradation behavior of 5Ca/5P, 25Ca/25P, and
25Ca/5P particles is similar regardless of formulation, with over 90% of particles degrading in within 7 days.
2
(B) Deposition of 25Ca/25P particles resulted in significantly more total silica (mg/cm ) being deposited onto
substrates than 5Ca/5P or 25Ca/5P particles. All comparisons were made using ANOVA, p-values < 0.05
were considered significant (* indicates statistical significance). Error bars and values expressed as ±SEM.

Mineralization
Ca/P sol particles were vapor deposited onto PS plates for 60 seconds, with
uncoated PS and PS coated with Ca/P free particles for 60 seconds to serve as controls,
and after exposure to SBF for 7 days mineral growth was assessed. SEM images show
that apatite-like mineral growth occurred in all groups, but mineral growth was much
more advanced in samples coated with all Ca/P particle formulations, though their
morphologies vary (Figure 3.6). EDS analysis showed that the Ca:P ratios for this
mineral is similar for all Ca/P formulations (5Ca/5P = 1.29±0.08; 25Ca/25P = 1.32±0.02;
25Ca/5P = 1.29±0.03; p=0.8).
3-D Application of Vapor Deposition Methods
3-D porous scaffolds were either left uncoated (Figure 3.7A), coated with Ca/P
free particles for 90 seconds (Figure 3.7B), or coated with 5Ca/5P particles for 90
seconds (Figure 3.7C) and exposed to SBF for 7 days all showed apatite-like mineral
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growth on the surface of the scaffolds. However, mineral growth was most significant on
scaffolds coated with Ca/P particles, with the mineral crystals uniformly covering the
scaffold surface. EDS analysis or the mineral on scaffolds coated with 5Ca/5P particles
revealed a Ca:P ratio of 2.08±0.13.

72

73
Figure 3.6. Apatite-like mineral growth with Ca/P sol particles. SEM images of mineral growth induced by PS Controls, Ca/P free particles, 5Ca/5P,
25Ca/25P, and 25Ca/5P particles deposited onto PS for 60 seconds after exposure to SBF for 7 days. All three Ca/P particles formulations show more apatitelike mineral growth than either the PS controls or the Ca/P free particles.
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Figure 3.7. Apatite-like mineral growth on 3-D porous fibrin scaffolds. Sphere-templated fibrin scaffolds vapor coated with (A) no particles, (B) particles
containing no calcium or phosphate for 90 seconds, or (C) 5Ca/5P particles for 90 seconds and exposed to SBF for 7 days. Scaffolds with no particles show
minimal mineral growth, while scaffolds coated with Ca/P free particles show more apatite-like mineral growth. However, scaffolds coated with 5Ca/5P particles
show uniform apatite-like mineral growth on the entire scaffold surface (EDS analysis shows calcium to phosphate ratio (Ca:P) of 2.08±0.13).

DISCUSSION
Sol-gels can be used as carriers for an abundance of molecules including ions,
proteins, drugs, RNA, and DNA. This work aimed to incorporate calcium and phosphate
into the developed vapor deposited particles to make them more bioactive. The addition
of these ions will change how the internal silica network forms, so it was necessary to
characterize the morphology and size distribution of the particles. Particles resulting from
5Ca/5P and 25Ca/5P solutions had regular rounded morphology similar to that of
unloaded particles (Figure 3.3, Figure 3.8). However, 25Ca/25P particles were more
irregularly shaped. This may be due to the water that is added to the solution with the
addition of the ions, but is unlikely because the particles did not crack as the excess water
evaporated, leading to the conclusion that this change in morphology is due to the
increased concentrations in calcium and phosphate. Additionally, the average particle
area was larger for all three Ca/P sol particle formulations, than for particles without the
ions (0.076±0.01 µm2 at t=60 seconds). This could be due to the more disrupted silica
network in the Ca/P sol particles through the addition of ions. Phosphate is known to
increase the surface area when incorporated into a bioactive glass [144, 147-149]. The
fact that the Ca/P sol particles generated have a relatively wide size range may be
beneficial to bone formation. Bioglass particles with narrow (300-360µm) and wide (90710µm) size ranges were implanted into femur defects. At 4 and 12 weeks, the defects
amount of bone generated in the grafts using the wide size range particles was larger and
had biomechanical properties equivalent to native bone [151].
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Figure 3.8. Size distribution and morphology of vapor deposited particles containing no additional
ions. Sol-gel solutions containing no calcium or phosphate ions have similar size distributions and
morphology to that of 5Ca/5P and 25%Ca/5P particles.

Deposition of all three Ca/P particles onto substrates decreased the contact angle
of the overall surface, making them more hydrophilic, with the largest change resulting
from the deposition of 25Ca/25P particles. This may be due to the larger surface area that
is covered by the larger 25Ca/25P particles, allowing for more interaction between water
and the particles as opposed to the other two formulations, which generated smaller
particles (Figure 3.4A).
The sol particles degraded more quickly with the addition of calcium and
phosphate ions (day 1: blank = 36.3±4.6% degraded; 5Ca/5P = 56.1±4.3%; 25Ca/25P =
86.1±10.7%; 25Ca/5P = 90.1±4.2%). This is due to the effect that calcium and phosphate
ions have on a bioglass network. The connectivity of a bioglass network is determined by
the composition and synthesis method of the glass. When the content of silica is high, the
network is highly connected and contains a large proportion of bridging oxygen bonds.
Connectivity is lowered by adding network modifiers (e.g. calcium and sodium) that are
known to disrupt the silica network through non-bridging oxygen bonds [107, 152, 153].
Conversely, phosphate that is added to a bioglass is found to be isolated from the silica
network and can remove calcium ions from their network modifying role, leading to
faster release into the aqueous environment and making the bioglass more soluble overall
[107, 154, 155].
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Though the particles successfully induced apatite-like mineral formation on 2-D
substrates that was superior to the mineral growth on uncoated PS substrates and PS
coated with Ca/P free particles, the Ca:P ratio was only around 1.3 for all Ca/P particle
formulations. Native bone HA is often defined of having a Ca:P ratio of 1.67 so most
bioactive materials aim to induce mineral formation at this benchmark. However, the
actual Ca:P ratio for bone mineral ranges from 1.57-1.71, and changes with the stage of
mineral maturation-increasing from 1.35 in early calcification of nodules [156] Altering
the amount of calcium and phosphate available for release within the particles to the
aqueous environment may lead to changes in the composition of the apatite mineral
formed on the substrate to achieve a Ca:P ratio closer to mature bone HA. It would also
be beneficial to determine the mineral composition in vivo since this would more
accurately determine particle ability to generate mineral that is close to that of native
bone. The calcium and phosphate Ca/P formulations that were used in this work were
chosen because the addition of higher concentrations of calcium chloride and triethyl
phosphate (i.e., 5M and 10M solutions) resulted in particles that were irregularly shaped
and varied greatly from sample to sample (Figure 3.9). It has been noted that successful
incorporation of calcium ions into silica nanoparticles makes it difficult to generate
particles of a more regular morphology [107, 157]. A 25 v/v% solution (1M) was chosen
because the addition of higher concentrations was found to have a dilution effect on the
solution. This resulted in a limit on the amount of calcium and phosphate that could be
incorporated into the sol particles using this technique and led to a fairly low amount of
calcium and phosphate in the overall composition of the particles, especially when
compared to that of traditional melt bioglasses which can be composed of up to 50 mol%
calcium [158]. A possible solution to this is adding the calcium and phosphate solutions
at the beginning of synthesis during hydrolysis, before the silica network has had a
chance to form or through careful adjustment of sol pH [107, 159].

77

Figure 3.9. Examples of Ca/P sol particles generated from higher concentrations of calcium and
phosphate. Solutions where higher concentration of CaCl2 and TEP were added [(A) 5 v/v% 10M Ca/5 v/v%
5M P, (B) 25 v/v% 5M Ca/5 v/v% 5M P, (C) 25 v/v% 5M Ca/25 v/v% 5M P] resulted in particles that were
highly irregular in morphology, composed of multiple phases, and displayed significant variability between
batch preparations, for this reason 1M solutions were chosen for generating Ca/P sol particles.

Vapor deposition of Ca/P sol particles and successful mineral growth on porous 3D scaffolds illustrates that these particles have the potential for application to structural
biomaterials used in tissue engineering. The mineral growth on the 3-D scaffolds had a
Ca:P ratio that was higher (2.08±0.13) than that of the mineral generated on 2-D
substrates using the same Ca/P formulation (1.29.±0.08). This is because the generated
mineral composition is dependent upon many factors including ion concentration, pH and
movement of the body fluid, as well as the spatial organization of the surface [114, 160].
Additionally, the presence of a polymer (in this case: fibrin) can alter the composition of
the mineral due to the incorporation of the polymer into the mineral layer [160, 161]. The
high Ca:P ratio of the 3-D mineral indicates that it is highly insoluble, as mineral
solubility increases with decreasing Ca:P ratios. This system developed here is a simple
and versatile platform for Ca/P sol particle generation and upon further optimization, it
could be possible to generate several different formulations of Ca/P sol particles-some of
which could be used promote interface stability and others that could be applied to tissue
engineering constructs. However, more work will need to be done in order to overcome
some limitations including the thickness of scaffold that the sol particles can penetrate
into. Potential solutions to this problem could be the application of a low-level vacuum to
the vaporization chamber to pull sol particles through the scaffolds as they are being
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generated and deposited or by incorporation of the sol particles into the fibrin structure
itself to create a polymer-ceramic composite material.
CONCLUSION
This work establishes that vapor deposited particles with incorporated calcium
and phosphate ions can successfully induce apatite-like mineral on both two- and threedimensional substrates superior to the mineral generated on untreated controls and
samples coated with Ca/P free particles, demonstrating their potential to be used as a
surface modification technique for other biomaterials to increase their bioactivity.
However, further work needs to be done to improve the properties of the particlesspecifically increasing particle stability in order to prolong the physical (generated
topography and increased surface hydrophilicity) and chemical (ion release) properties
that result from the vapor deposition of these particles onto surfaces, as well as
optimization of calcium and phosphate content used, in an effort to further tailor the
composition of the resultant mineral.
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CHAPTER FOUR: OSTEOBLAST RESPONSE TO
CALICIUM-PHOPHATE SOL PARTICLES 3
This chapter addresses Specific Aim 3—assessment of osteoblast behavior in response to
the vapor deposited calcium-phosphate loaded sol particles characterized in Chapter 3
and evaluation of their of potential to be used to direct osteoblast attachment,
proliferation, and differentiation in orthopedic tissue engineering applications.
INTRODUCTION
Native biological tissues are complex and composed of a variety biomolecules to
create a heterogeneous environment whose structure is organized so that it creates a
hierarchy ranging from nano- to micro- to macro-scale [162-165]. The physical and
chemical properties of the tissue generate a particular set of cues for cells to promote
proper cell behavior [164, 166-168]. Biomimetic materials aim to imitate the natural
cellular micro-environment in order to promote tissue regeneration. More specifically, it
is important to design materials with the minimal character to target desired cell behavior
for tissue regeneration [168-175].
Surface roughness and topography, as examples, can significantly influence
osteoblast behavior. It is widely accepted that implants with roughened surfaces display
increased osseointegration [65-70]. Osteoblasts cultured on materials with high surface
roughness (100-500nm) display increased attachment, compared to cells cultured on
smoother substrates [176-183]. The coexistence of hierarchal nano- and micro-structures
on a substrate surface (Figure 4.1) allows for greater interaction between the cell and the
material and can induce both osteoblast proliferation and differentiation [183, 184]. Cells
cultured on these materials have been found to have higher ALP activity, type I collagen
and osteocalcin expression, prostaglandin E2 (PGE2) and transforming growth factor
beta 1 (TGF-β1) production, as well as calcium deposition [80, 163, 183-186].
Additionally, the organization of the nano- and micro-structure can have a significant
effect on osteoblast behavior. Less ordered surface topography results in increased
3

The material presented in this chapter is in preparation for submission to the Journal of Biomedical
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osteoblast phenotypic character compared to that of highly ordered arrays in which cells
develop a fibroblast phenotypic [80].
In addition to surface roughness and topography, surface hydrophobicity
(wettability) can also play a significant role in protein adsorption and cell behavior [57,
187-189]. Hydrophilic surfaces (θ < 65°) allow for enhanced interaction between a
substrate surface and its biologic environment, due to the ability to form covalent, ionic,
hydrogen and charge-transfer bonds leading to increased cell adhesion and spreading [57,
190-195]. Osteoblasts exhibit elevated osteoblast specific gene expression (osteocalcin
and osteoprotegrerin) as well as increased prostaglandin E2, transforming growth factor
β1, and vascular endothelial growth factor (VEGF) production, ultimately demonstrating
increased differentiation on substrates that are more hydrophilic [182, 196-199].
Importantly, surface hydrophobicity effects on cell behavior are time dependent, guiding
early activation and differentiation with effects that diminish over time (within 3 days)
[57, 200].
Silica based bioactive glasses, including sol-gels, possess the ability to actively
influence cell behavior including osteogenesis and angiogenesis, as well as enhance
antibacterial activity (see Figure 1.7) [4]. In addition to roughness, topography, and
hydrophobicity, dissolution ions (Si, Ca, P) introduced to the surrounding medium have
been found to influence the behavior many tissue specific cell types including
mesenchymal stem cells, osteoblasts, osteoclasts, fibroblasts, and endothelial cells [4,
104].
Osteoblasts exposed to silicate ions show increased proliferation, collagen I
production (10-20µM), ALP activity, osteocalcin expression, and ECM mineralization
(15-20µg/ml) depending on the concentration of silica ions and cell line used [117, 118,
120, 122, 201]. Extracellular calcium and phosphate ions can have a significant impact on
osteoblast proliferation, differentiation, and ECM production [12]. Calcium acts as a
signaling molecule in many cell processes and pathways and can promote osteoblast
migration, proliferation, and differentiation through the activation of calcium sensing
receptors (CaSR/CaR), the extracellular signal-regulated kinase (ERK 1/2) pathway, and
increases in intracellular calcium levels, with maximum effects being treatment dosages
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between ~3-10mM [123-125, 202-204]. Phosphate ions (5-10mM) also play a role in
bone remodeling and help to regulate osteoblast differentiation, increasing expression of
transcriptional factors (e.g. Nrf2, HMGA1 and 2), signal transduction factors (e.g.
calcyclin, A170), plasma membrane and membrane transport factors (e.g. Pit-1, Annexin
V), as well as the extracellular matrix protein, osteopontin [128, 130].
Again as with other material properties, the influence of dissolution ions is dose
and time dependant in nature. Osteoblast precursors exposed to calcium ions at
concentrations slightly higher than physiologic levels (2-4mM) show increased cell
proliferation, while at even higher levels (6-8mM) differentiation and matrix
mineralization are enhanced, but with a decrease in cell viability [126]. Excessive
calcium levels (>10mM) are cytotoxic [5, 125, 126, 205]. Similarly, treatment of cells
with phosphate ions causes a dose and time dependant (high concentrations and exposure
times) increase in chondrocyte and osteoblast apoptosis, while also contributing to
terminal differentiation [128, 132, 133]. For example, treatment of osteoblast-like cells
with Pi for 48 hours at concentrations of 5 mM and 7mM led to 75% and 40% cell
viability respectively, while after 96 hours of treatment with 5 mM Pi led to 30% viability
and

7 mM caused almost complete cell loss [132]. Ion concentrations that are

appropriate to ensure viability, while promoting cell differentiation and matrix maturation
remain unclear, and understanding the mechanisms controlling these relationships
warrants further investigation.
The Ca/P sol-particles developed and characterized in Chapter 3 allow for the
modification of biomaterials by generating unique surface nano- and micro-topography
and decreasing surface hydrophobicity. These particles also release calcium and
phosphate ions as they degrade and induce apatite-like mineral formation. The goal of
this work is to assess osteoblast behavior in response to these vapor deposited Ca/P sol
particles. Cell attachment, proliferation, and gene expression were evaluated.
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Figure 4.1, Diagram of interaction of bone tissue and cells with a material at different topographical
scales. From Gittens et al. with permission (see Appendix A) [184].

MATERIALS AND METHODS
Sol Preparation and Vapor Deposition
The base compositions of the sol solutions used in these experiments was a 16:1
molar ratio of de-ionized water to tetramethyl orthosilicate (TMOS; Sigma Aldrich). Sol
was vapor deposited using the developed vaporization chamber onto non-tissue culture
polystyrene (PS) for 60 seconds at 40psi. Samples were removed immediately after
deposition and the sol was allowed to fully polycondensate into a solid gel for 2 minutes.
Samples were covered and stored at 25°C for 3-7 days until further use.
Calcium and Phosphate Incorporation into Sol
Calcium (Ca) and phosphate (P) ions were incorporated into solutions just before
vapor deposition by adding 1M calcium chloride (CaCl2; Sigma Aldrich) and 1M triethyl
phosphate (TEP; Sigma Aldrich) in three different formulations (v/v%): 5% Ca/5% P,
25% Ca/25% P, and 25% Ca/5% P.
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Cell Attachment and Proliferation
MC3T3-E1 Subclone 4 osteoblast progenitors (ATCC) were cultured directly on
plates coated with particles (5Ca/5P, 25Ca/25P, 25Ca/5P, and Ca/P free) or non-tissue
culture PS as a control (seeding density: 1x104 cells/cm2) at 37°C and 5% CO2 in
Minimal Essential Media (α-MEM; Hyclone) supplemented with 10% fetal bovine serum
(FBS; Hyclone) and 1% penicillin-streptomycin (P/S; Mediatech). All samples were
sterilized using ethylene oxide and rinsed three times with sterile phosphate buffered
saline (PBS) before cell seeding. At days 1 and 2, cells were fixed (4%
paraformaldehyde), stained (TRITC-conjugated Phalloidin and 4',6-diamidino-2phenylindole, DAPI; Molecular Probes, Invitrogen), and imaged (Olympus BX5
microscope). Cell attachment was quantified through direct cell counts and normalized to
the cell seeding density.
To determine cell proliferation, at days 1 and 2 cells were fixed (4%
paraformaldehyde) and stained using the proliferation marker, Ki-67 (SP6) primary
antibody (Abcam) with Alexafluor-488 conjugated secondary antibody (Abcam). Cell
nuclei were stained using DAPI. Ki-67 positivity was quantified through direct cell
counts and calculated by dividing the number of Ki-67 positive cells by the number of
total cells [206].
Gene Expression
MC3T3-E1 Subclone 4 preosteoblasts were cultured directly on plates vapor
coated with Ca/P particles, Ca/P free particles or PS as a control (n=6/group) (1x104
cells/cm2) at 37°C and 5% CO2 in α-MEM supplemented with 10% FBS and 1% P/S. At
days 1, 2, and 4 RNA was isolated using TRIzol® (Invitrogen) according to the
manufacturer instructions and RNA concentration and quality was determined using
spectrophotometer readings at 230, 260 and 280nm (Nanodrop ND-1000). RNA was
reverse transcribed into cDNA using Superscript® II Reverse Transcriptase (Invitrogen),
1X first-strand buffer (Invitrogen), 48mM dithiothreitol (DTT; Invitrogen) 800µM
dNTPs, (Promega), RNaseOUT™ Recombinant Ribonuclease Inhibitor (Invitrogen), and
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0.5µg Oligo(dT)12-18 Primer (Invitrogen) at 42°C for 20 minutes, 50°C for 10 minutes and
42°C for 60 minutes. cDNA was then used for real time PCR for genes of interest (GOI)
and housekeeping genes (HK) (Table 4.1). All reactions were performed in the
StepOnePlus™ real-time PCR system (Applied Biosystems) under the following
parameters: hot start at 95°C for 15 minutes followed by 40 cycles at 95°C for 15
seconds, 60°C for 30 seconds and 72°C for 15 seconds. GOI expression levels relative to
the geometric mean of housekeeping genes Ubiquitin and Cyclophilin were calculated
using the 2(-ΔΔCt) method [207].
Mineralization- Alizarin Red and Alkaline Phosphatase
MC3T3 preosteoblasts were cultured directly on plates vapor coated with Ca/P sol
particles or PS as a control

(1x104 cells/cm2) at 37°C and 5% CO2 in α-MEM

supplemented with 10% FBS, 1% P/S and 50µg/ml ascorbic acid. Media was changed
every 3 days. At days 4, 7, 10, and 14 cells were fixed with neutral buffered formalin
(NBF) overnight.
Cultures were stained for either calcium content (alizarin red) or alkaline
phosphatase (ALP). For alizarin red, cells were stained (2w/v% alizarin red in dH2O and
pH adjusted to 4.1-4.3) for 30 minutes at room temperature, washed with dH2O and
imaged. For ALP activity, cells were stained with Naphthol AS-MX phosphate
(0.1mg/ml)/diazonium salt (fast red violet LB salt; 0.6mg/ml) in 50% Tris-HCl (pH
8.74)-50% dH2O for 60 minutes at 37°C, washed with dH2O and imaged.
Statistics
All experiments were performed in triplicate (n=3) unless otherwise stated. Data
was analyzed for significance using an analysis of variance (ANOVA) and a Tukey’s
post-hoc test for pairwise comparison, except for gene expression data where each
treatment group was compared to controls using a Student’s t-test.

Statistical

significance defined as a p value less than 0.05 (p<0.05). Error bars in text and on graphs
represent standard error of the mean (±SEM).
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Table 4.1. Genes and primer sequences used in PCR reactions

RESULTS
Cell Attachment and Proliferation
MC3T3 preosteoblasts cultured on substrates coated with Ca/P sol particles
showed similar morphology to those cultured on polystyrene controls, with cells spread
out on the substrate surface (Figure 4.2A). Relative cell attachment (normalized to
uncoated PS) at day 1 (control = 1.00±0.15; Ca/P free = 1.59±0.22; 5Ca/5P = 0.97±0.07;
25Ca/25P = 1.17±0.17; 25Ca/5P = 1.22±0.14) showed significantly higher attachment on
plates coated with Ca/P free particles compared to plates coated with 5Ca/5P particles
(p=0.0049) and by day 2 (control = 1.00±0.12; Ca/P free = 1.88±0.24; 5Ca/5P =
0.79±0.11; 25Ca/25P = 0.91±0.07; 25Ca/5P = 0.84±0.08) significantly higher attachment
on plates coated with Ca/P free particles compared to all groups (Figure 4.2B;
p=0.0003). This indicates that cell attachment during days 1 and 2 is enhanced when Ca/P
free particles are deposited onto PS substrate, while deposition of Ca/P particles does not
increase cell attachment compared to controls.
Cell proliferation, as indicated by the fraction of total cells positively expressing
of the proliferation marker, Ki-67 was assessed (Figure 4.3A). At day 1, the fraction of
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Ki-67 positive cells (control = 0.53±0.03; Ca/P free = 0.74±0.04; 5Ca/5P = 0.45±0.02;
25Ca/25P = 0.57±0.02; 25Ca/5P = 0.60±0.01), on PS coated with Ca/P free particles was
significantly higher compared to PS controls and all Ca/P particle formulations
(p=0.007). Additionally, the fraction of Ki-67 positive cells was significantly lower in
5Ca/5P cultures compared to 25Ca/5P cultures (p=0.006). At day 2 the fraction of Ki-67
positive cells (control = 0.78±0.04; Ca/P free = 0.74±0.03; 5Ca/5P = 0.58±0.02;
25Ca/25P = 0.77±0.05; 25Ca/5P = 0.78±0.02) was significantly lower in 5Ca/5P particle
cultures compared to all other groups (Figure 4.3B; p<0.006). This indicates that cell
proliferation is initially enhanced in cells cultured with Ca/P particles compared to
controls while it is decreased in cells cultured with 5Ca/5P particles.
Gene Expression
Gene expression of MC3T3 preosteoblasts cultured with Ca/P free and Ca/P sol
particles was analyzed using quantitative PCR at days 1, 2, and 4. Osteoblast
differentiation markers Runx2, osteopontin, (OPN), osteocalcin (OCN), and type I
collagen were genes of interest and expression levels were normalized to housekeeping
genes ubiquitin and cyclophilin (Table 4.2). There is a trend that is suggestive of an early
up-regulation event of the master osteoblast differentiation regulator Runx2 expression in
cells cultured with all Ca/P particle formulations at days 1 and 2 compared to controls
(Figure 4.4A). Although the data did not reach the critical level for significance, these
findings suggest that the presence of the particles themselves have the potential for
accelerating commitment to an osteogenic phenotype. OPN expression was significantly
increase in cells cultured with Ca/P free particles at day 2 (p=0.02) and shows a trend of
upregulation at days 2 and 4 in cells cultured with Ca/P particles (Figure 4.4B).
Similarly, OCN expression in osteoblasts cultured with Ca/P particles was upregulated at
days 1, 2, 4 (statistical significance 25Ca/5P at day 2; p=0.001) and downregulated in
cells cultured with Ca/P free particles at day 1 (p=0.02; Figure 4.4C). ColI expression
was down regulated in cells cultured with particles (Ca/P free and Ca/P) at day 2
compared to controls (statistical significance in 25Ca/25P cultures p=0.01; Figure 4.4D).
The upregulation of Runx2, OPN, and OCN expression in osteoblasts cultured with Ca/P
particles shows that they have to potential to induce early osteoblast differentiation.
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Figure 4.2. Osteoblast attachment in response to Ca/P sol particles. MC3T3 preosteoblasts were cultured on non-tissue culture PS dishes that have been
vapor coated with Ca/P sol particles (5Ca/5P, 25Ca/25P, 25Ca/5P) for 60 seconds, with uncoated PS plates and PS plates coated with Ca/P free particles for
60 seconds serving as controls. (A) At days 1 and 2, cells were stained using TRITC-conjugated Phalloidin and DAPI and cell attachment was assessed (scale
bar = 500µm). (B) Relative cell attachment (normalized to uncoated PS) at day 1 showed a significantly higher attachment on plates coated with Ca/P free
particles compared to plates coated with 5Ca/5P particles and by day 2 significantly higher attachment on plates coated with Ca/P free particles compared to
all groups. All comparisons were made using ANOVA, p-values < 0.05 were considered significant. Error bars represent ±SEM.(# indicates statistical
significance to a second group within time point. * indicates statistical significance to all groups within time point).
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Figure 4.3. Osteoblast Ki-67 expression in response to Ca/P sol particles. MC3T3 preosteoblasts were cultured on non-tissue culture PS vapor coated
with Ca/P sol particles (5Ca/5P, 25Ca/25P, 25Ca/5P) for 60 seconds, with uncoated PS and PS coated with Ca/P free particles for 60 seconds as controls. (A)
At days 1 and 2, Ki-67 expression was assessed. (Inset- corresponding DAPI image showing cell nuclei; scale bar = 500µm). (B) At day 1 the fraction of Ki-67
positive cells on PS coated with Ca/P free particles was significantly higher compared to PS controls and all Ca/P particle formulations. Additionally, the
fraction of Ki-67 positive cells was significantly lower in 5Ca/5P cultures compared to 25Ca/5P cultures. At day 2 the fraction of Ki-67 positive cells was
significantly lower in 5Ca/5P particle cultures compared to all other groups. All comparisons were made using ANOVA, p-values < 0.05 were considered
significant. Error bars represent ±SEM. (# indicates statistical significance to a second group within time point. * indicates statistical significance to all groups
within time point).

Table 4.2. Gene expression of MC3T3 osteoblasts cultured with Ca/P sol particles
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Figure 4.4. Osteoblast gene expression in response to Ca/P sol particles. Quantitative PCR expression of osteoblastic differentiation markers (A) Runx2,
(B) osteopontin (OPN), (C) osteocalcin (OCN) and (D) collagen type I (COLI) show relative gene expression levels of MC3T3 preosteoblasts cultured with Ca/P
free, 5Ca/5P, 25Ca/25P, or 25Ca/5P particles deposited for 60 seconds normalized to cells cultured on untreated polystyrene (PS control) at days 1, 2, and 4.
All comparisons between treatment groups and control were made t-test, p-values < 0.05 were considered significant (* indicates statistical significance
compared to control) Error bars represent ±SEM.

Mineralization Alizarin Red and ALP Staining
Cells cultured with Ca-P particles and stained for alizarin red after 14 days of
culture show increased calcium deposition compared to controls especially in 5Ca/5P
cultures, indicating a higher degree of mineralization in these cultures (Figure 4.5). ALP
staining of cultures at day 14 was inconclusive (data not shown).

Figure 4.5. Mineralization of osteoblasts in response to Ca/P sol particles. MC3T3 preosteoblasts were
cultured on non-tissue culture PS dishes that have been vapor coated with Ca/P sol particles (5Ca/5P,
25Ca/25P, 25Ca/5P) for 60 seconds, with non-coated PS plates serving as controls (with and without media
containing 50µg/ml ascorbic acid; AA). At day 14 cultures, were stained to assess calcium deposition
(alizarin red) (scale bar = 500µm).

DISCUSSION
Osteoblast attachment and proliferation in cultures treated with Ca/P sol particles
showed no significant differences when compared to control cultures, with the exception
of 5Ca/5P cultures at day 2, where those cells showed significantly less proliferation.
When cells begin to differentiate, their proliferation rate slows [25]. This, in conjunction
with the increased Runx2, OPN and OCN expression at day 1 and the increased calcium
deposition (i.e. alizarin red staining) suggest that particles containing calcium and
phosphate may enhance osteoblast differentiation.
The gene expression data suggests that the there is a trend of upregulation in
osteoblasts cultured with Ca/P sol particles when compared to control cultures. Runx2 is
often considered the master transcription factor for commitment of cells to the osteoblast
lineage in both endochondral and intramembranous ossification. Additionally, Runx2 is
needed to ensure mature osteoblasts function properly by triggering their synthesis of
many extracellular matrix genes, including type I collagen. Runx2 gene expression and
protein function is regulated at various levels including transcription, translation, and
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post-translational modification through a variety of pathways [208-210]. The data in this
work is promising because without the upregulation of Runx2 expression, cells will not
differentiate into osteoblasts. Additionally, the trend for up-regulated collagen expression
in cells cultured with Ca/P sol particles further implies that these particles hold the
potential to direct osteoblast differentiation with further modification of the system.
When designing a silica based material for drug/molecule delivery there are many
aspects that need to be taken into account including: the particle size, shape, and structure
(pore network size, connectivity and volume). These properties can all be influenced by
the synthesis parameters as well as any post-generation treatments such as thermal
treatment or surface functionalization. Changing any of these features can dramatically
influence the incorporated agents are released. Additionally, how the molecule interacts
with the silica network will influence its ability to be incorporated as well as its release
kinetics [211-214]. The influence of all of these factors is why developing a successful
material system to deliver bioactive factors can be extremely difficult.
The borderline significant differences in gene expression between control cultures
and Ca/P sol particle cultures, indicates that the formulation of calcium and phosphate
will need further optimization--possibly by increasing the deposition time of particles in
order to increase the number of particles cells are exposed to and/or using a particle
formulation with slower degradation characteristics in order to prolong the exposure
particle material chemical (i.e. ion release) and physical (i.e. topography, surface
hydrophobicity) properties to the osteoblast cells. Currently, the Ca/P sol particles
designed in this work degrade within the first 3 days of culture, so any effects they induce
are at the early time points. In order to fully induce osteoblast differentiation a threshold
that was not reached with these particle formulations and/or sustained ion release may be
required.
Particle stability could be increased by aging particles using temperature curing
for example. Increasing the drying time and temperature will promote the densification
(decrease in pore size) of the silica network, thus controlling the degradation rate, which
is especially important in systems designed for drug/molecule release [86, 105, 215, 216].
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Many sol-gel applications currently being developed involve a step where the material is
heated to 400-600°C, which aids in incorporating calcium into the silica network as well
as dramatically improving the stability of the material [217-220]. Though this step can
help to improve the properties of the sol-gel material, it prevents the addition of any
temperature sensitive polymers and/or biological molecules, thus limiting its use.
Perhaps a better solution to increasing the stability of the Ca/P sol particles is to
generate an inorganic-organic hybrid material. These materials incorporate a polymer
into the silica network at the beginning stages of sol-gel synthesis, so that the silica
network forms around the polymer molecules (Figure 4.6). The two materials interact on
the nano-level, allowing them to behave as a single phase material. Hybrid materials take
advantage of the properties of both the inorganic (e.g. hardness, strength, thermal
stability, density, etc.) and the organic (e.g. elasticity, hydrophobic character, chemical
reactivity) components to generate materials that have improved mechanical and
degradation properties that would not be possible otherwise [221]. For example collagensilica hybrid films (thickness = 100-200µm) degraded only about 50% of its mass in 14
days in PBS at 37°C [222] In hybrid synthesis, the polymer is added to the sol-gel during
condensation, where the chain-like structure of the silicate can entangle with the polymer
chains [107-109]. Though hybrid materials have improved properties, there are several
challenges that must be considered: 1) the chosen polymer must soluble in the sol–gel
solution and have suitable degradation characteristics; and 2) the conditions in which solgel is produced under can degrade the polymer so the pH must be carefully controlled to
balance degradation and gelling time [107, 109, 110]. Currently polymers that are used in
hybrid materials include poly(methyl methacrylate)-PMMA, poly(diemthylsiloxane)PDMS, poly(tetramethylene oxide)-PTMO, poly(2-hydroxyethyl methacrylate)-pHEMA
,and polycaprolactone-PCL, as well as the natural polymers gelatin, collagen, chitosan,
alginate, and poly(γ-glutamic acid)-γPGA [7, 107, 221].
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Figure 4.6. Schematic of an inorganic-organic hybrid material. The silica network is linked to the
polymer chains by a coupling agent-the carboxylic acid groups on the polymer act as nuclophiles to form a
bond. From Jones with permission (See Appendix A)[107].

CONCLUSION
The vapor deposition method established here allows for simple means of
generating silica sol particles where calcium and phosphate ions can be incorporated.
These Ca/P sol particles have been shown to hold the potential to direct osteoblast
behavior. This system can now be optimized to address issues regarding particle stability.
To address this, the development of an inorganic-organic hybrid material for the sol
particles is an attractive approach.
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CHAPTER FIVE: CONCLUSIONS
SUMMARY AND KEY FINDINGS
Six million bone fractures occur annually in the U.S., 5-10% of which result in
non-unions or delayed unions indicating there is a growing need for the development of
material substitutes and therapies to address this problem [1]. Tissue engineering and
regenerative medicine have emerged in an effort to generate replacement tissues capable
of restoring native tissue structure and function [2]. Because of the complexity of
biologic systems, it has proved to be much harder to design substitute matrices for cells
than originally anticipated. Cells are affected by the chemical and molecular composition
of the implanted material, as well as by its physical properties. Development of materials
that utilize the relationships between cells and material chemical, physical, and
mechanical properties may provide a better platform for tissue regeneration [3]. Silica
based bioactive glasses are most prominently associated with orthopedic applications in
both traditional implants as well as hard and soft tissue engineering materials [102].
These materials have been known to enhance osteogenesis and angiogenesis as well as
promote antibacterial activity [4, 223]. Sol-gels are attractive as a bioglass generation
method because of their mild processing conditions, the ability to control structure and
composition through their synthesis parameters, the ability to incorporate a variety of
biological molecules, and their inherent biocompatibility [6, 7, 87, 88, 105]. Further, they
possess the capacity to exert an inherent active influence on cell behavior; modulated in
part by surface chemistry, topography, and active agents incorporated in the sol-based
material. However, the exact balance of these parameters that is most appropriate for
directing cell function and gene expression is not fully understood and warrants further
exploration [104, 205, 224]. The goal of this work was to develop and characterize a
bioactive silica sol-gel surface modification system that can be used to tailor their
material properties at the nano- and micro- level to better mimic the instructive
conditions of native bone tissue, promoting appropriate osteoblast attachment,
proliferation, and differentiation as a means for supporting bone tissue regeneration. The
findings of this work are summarized below:
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Chapter 2
Vapor deposited silica sol-gel particle size distribution, morphology and degradation
are dependent upon various formulation and manufacturing parameters including:
H2O:TMOS, solution pH, underlying substrate character, and deposition time.
•

The H2O:TMOS affects particle size distribution through changes in the amount of H2O
available for hydrolysis, which effects gelation time. At a ratio below approximately 8:1,
increasing H2O content, decreases the gelation time, while at ratios above 8:1 the increased
H2O acts as a diluent, causing a decreasing in gelation time [86, 105].

•

Solution pH will significantly affect particle properties. Solutions near the silica isolectric
point (pH=2-3) will have the longest gelation times and as pH increases gelation time
decreases. Solutions with pH 5-6 have the greatest instability and quickest gelation time.
Below the isolectric point the solubility of silica decreases and leads to metastable solutions,
and a silica network has trouble forming [86, 105].

•

Substrate surface character plays a role in particle size distribution due to the interaction of
substrate chemistry, hydrophobicity and roughness on the sol-gel as it is deposited.

•

Deposition time has a larger effect on particle properties when the sol formulation has a
longer gelation time.

•

Deposition of sol particles changes the overall surface properties of a material, decreasing
surface hydrophobicity and increasing surface roughness with increasing deposition time, as
well as generating a unique surface topography.

•

Osteoblast attachment increases on substrates coated with silica sol particles during the first
48 hours of culture due to both changes in the surface properties as well as silica ions release
into the surrounding culture media.

Chapter 3
Calcium and phosphate ions can be incorporated into the vapor deposited sol-gel
particles, and their size distribution and morphology is dependent upon the concentration
of ions added, with higher concentrations of calcium and phosphate yielding larger, less
rounded particles.
•

The degradation rate of Ca/P sol particles is largely independent of added ion concentration,
with an average, effective mass loss of 90% within 7 days.
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•

Ca/P sol particles decrease overall substrate surface hydrophobicity, with increasing calcium
and phosphate ion concentration.

•

Exposure to simulated body fluids generated apatite like mineral formation within 7 days for
all particle formulations.

•

Ca/P sol particles can be vapor deposited onto three-dimensional porous scaffolds and induce
uniform surface apatite-like mineral nucleation and growth, demonstrating potential use as a
surface modification technique for bone tissue engineering.

Chapter 4
Osteoblasts cultured on Ca/P sol particles showed no significant differences in
cell attachment within 48 hours compared to controls. Cell proliferation in these cultures
was also similar to controls with the exception of cells cultured with 5Ca/5P particles,
which showed decreased cell proliferation. This is promising, because differentiating
osteoblasts have decreased proliferation rates [225].
Gene expression in osteoblasts cultured with Ca/P sol particles shows a trend of
up-regulated Runx2 expression. Runx2 is the master transcription factor in the
commitment of cells to the osteoblast lineage [208, 210, 226]. Up-regulation of this gene
shows the potential for Ca/P sol particles to aid in osteoblast differentiation.
LIMITATIONS
This work is limited by several factors including that many of the conclusions
drawn regarding particle promotion of osteoblast differentiation are drawn from RTqPCR data. While this provides evidence of gene transcription, it does not necessarily
show that the gene was translated into protein expression. Alizarin red and ALP staining
attempted to demonstrate the calcium deposition (i.e., mineralization) and expression on
ALP in longer-term cultures, but the ALP stain was inconclusive. A more reliable and
quantitative method to assess protein expression would be western blotting. Additionally,
gene expression was only assessed at early time points. This may not have captured the
whole picture of how Ca/P sol particles influence cell behavior at later time points.
Perhaps the biggest limitation of this work is the stability of the generated
particles. Both unloaded silica and Ca/P sol particles degraded quickly when in culture
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(within 7 days), with the majority of degradation occurring within the first 3 days. This
limited the time that the particles were able to influence cell behavior, specifically full
differentiation of preosteoblasts and bone matrix production. If the degradation rate of the
particles could be slowed, their effects-induced both through changes in substrate
physical properties as well as chemically through the release of calcium and phosphate
ions could be sustained and have a greater impact.
FUTURE DIRECTION
Hybrid Materials
Incorporation of an organic material into the sol-gel formulation could greatly
improve the degradation properties of the particles. Polymers added to the solution early
in the sol-gel process allow the organic and inorganic portions to mix and interact very
closely with one another so that they behave as a single phase material [107, 108, 220].
The polymer chosen must be soluble in the sol-gel solution and the solution pH must be
carefully controlled to prevent polymer degradation as well as control the gelation time
[107]. Additionally, a hybrid material may alter the release characteristics of the Ca/P sol
particles, allowing for the incorporation of different concentrations of calcium and
phosphate and sustaining their release during culture.
Applications
The particles developed in this work could be used in a variety of applications.
They can be used to coat a variety of biomaterials, from three-dimensional scaffolds (see
Figures 3.1 and 3.6) to electrospun fiber mats (Figure 5.1), generating unique composite
composition and architecture. Many other biomolecules could be incorporated into these
sol particles in addition to calcium and phosphate ions in order to further enhance
osteoblast differentiation including but not limited to bone morphogenic protein (BMP),
transforming growth factor-beta (TGF-β), fibroblast growth factor (FGF), vascular
endothelial growth factor (VEGF), insulin-like growth factor (IGF), and parathyroid
hormone (PTH) [227-229]. A potential clinical application for these particles is with bone
allografts. Allografts are limited in their osteogenic and remodeling potential, with
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approximately 25-35% failing within 3 years due to fracture and nonunion. At 10 years,
the failure rate has been reported to be as high as 60% [230]. Coating these materials with
vapor deposited sol particles containing osteogenic factors may aid in integration of the
graft with native bone tissue and potentially reduce local immunogenicity.
In addition to orthopedic applications, the particles developed in this the work
have the potential to be used in a variety of other applications. Bioactive glasses have
recently been used in both soft tissue repair and angiogenesis [4, 223, 231]. Fibroblasts
and endothelial cells treated with bioactive glass particles have been found have
enhanced proliferation as well as produce high concentrations of VEGF, which stimulates
angiogenesis [232-234]. Vapor deposition of sol particles onto biomaterials designed for
soft tissue or cardiovascular applications may enhance effectiveness of these materials.
Further, these particles may be used to enhance the antimicrobial character of
biomaterials, by damaging bacterial cell structures, preventing biofilm formation through
increases in local pH. Incorporation of known antibacterial agents such as silver (Ag+)
ions and NO donor groups into the particles may further enhance these properties [4, 6].

Figure 5.1. Vapor deposition onto electrospun fibers. Particles were vapor deposited onto electrospun
PLLA fibers (arrow indicates vapor line created by masking) to demonstrate a potential application of
particles on a relevant biomaterial surface.
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